Chronic inflammatory disease epidemiology – Research group Johan Askling

Publications

All publications from group members

• Article: PSYCHOLOGICAL MEDICINE. 2023;53(15):7300-7308

  Maternal rheumatoid arthritis and risk of autism in the offspring.

  Yin W; Norrbäck M; Levine SZ; Rivera N; Buxbaum JD; Zhu H; Yip B; Reichenberg A; Askling J; Sandin S
• Article: CLINICAL GASTROENTEROLOGY AND HEPATOLOGY. 2023;21(12):3132-3142

  Increasing Risk of Lymphoma Over Time in Crohn's Disease but Not in Ulcerative Colitis: A Scandinavian Cohort Study.

  Olén O; Smedby KE; Erichsen R; Pedersen L; Halfvarson J; Hallqvist-Everhov Å; Bryder N; SWIBREG Study Group; Askling J; Ekbom A; Sachs MC; Sørensen HT; Ludvigsson JF
• Article: RHEUMATOLOGY. 2023;62(10):3391-3399

  Glucocorticoid exposure and the risk of serious infections in rheumatoid arthritis: a marginal structural model application.

  Barbulescu A; Sjölander A; Delcoigne B; Askling J; Frisell T
• Article: JOURNAL OF RHEUMATOLOGY. 2023;50(8):1009-1019

  One-Third of European Patients With Axial Spondyloarthritis Reach Pain Remission With Routine Care Tumor Necrosis Factor Inhibitor Treatment.

  Ørnbjerg LM; Rugbjerg K; Georgiadis S; Rasmussen SH; Lindström U; Pavelka K; Yilmaz N; Favalli EG; Nissen MJ; Michelsen B; Vieira-Sousa E; Jones GT; Ionescu R; Relas H; Sanchez-Piedra C; Tomšič M; Geirsson AJ; van der Horst-Bruinsma I; Askling J; Loft AG; Nekvindova L; Direskeneli H; Iannone F; Ciurea A; Fagerli KM; Santos MJ; Macfarlane GJ; Codreanu C; Eklund K; Pombo-Suarez M; Rotar Z; Gudbjornsson B; Rusman T; Østergaard M; Hetland ML
• Article: SCANDINAVIAN JOURNAL OF RHEUMATOLOGY. 2023;52(4):374-384

  Validity of clinical psoriatic arthritis diagnoses made by rheumatologists in the Swedish National Patient Register.

  Wallman JK; Alenius G-M; Klingberg E; Sigurdardottir V; Wedrén S; Exarchou S; Lindström U; Di Giuseppe D; Askling J; Jacobsson L
• Article: ANNALS OF THE RHEUMATIC DISEASES. 2023;82(7):911-919

  Cancer risks with JAKi and biological disease-modifying antirheumatic drugs in patients with rheumatoid arthritis or psoriatic arthritis: a national real-world cohort study.

  Huss V; Bower H; Hellgren K; Frisell T; Askling J; Behalf of the ARTIS group; behalf of the ARTIS group
• Article: EUROPEAN JOURNAL OF EPIDEMIOLOGY. 2023;38(7):809-819

  Repurposing antidiabetic drugs for rheumatoid arthritis: results from a two-sample Mendelian randomization study.

  Qin C; Diaz-Gallo L-M; Tang B; Wang Y; Nguyen T-D; Harder A; Lu Y; Padyukov L; Askling J; Hägg S
• Article: RHEUMATOLOGY. 2023;62(6):2106-2112

  The association between autoantibodies and risk for venous thromboembolic events among patients with rheumatoid arthritis.

  Westerlind H; Kastbom A; Rönnelid J; Hansson M; Alfredsson L; Mathsson-Alm L; Serre G; Cornillet M; Holmdahl R; Skriner K; Bang H; Klareskog L; Saevarsdottir S; Lundberg K; Grönwall C; Askling J
• Letter: RHEUMATOLOGY. 2023;62(6):e204

  Comment on: The association between autoantibodies and risk for venous thromboembolic events among patients with rheumatoid arthritis: reply.

  Westerlind H; Kastbom A; Askling J
• Article: ANNALS OF THE RHEUMATIC DISEASES. 2023;82(6):820-828

  Uptake and effectiveness of newer biologic and targeted synthetic disease-modifying antirheumatic drugs in psoriatic arthritis: results from five Nordic biologics registries.

  Glintborg B; Di Giuseppe D; Wallman JK; Nordström DC; Gudbjornsson B; Hetland ML; Askling J; Grondal G; Sokka T; Provan SA; Michelsen B; Kristianslund EK; Dreyer L; Love TJ; Lindström U
• Article: JOURNAL OF RHEUMATOLOGY. 2023;50(6):781-788

  The National Prevalence of Clinically Diagnosed Psoriatic Arthritis in Sweden in 2017.

  Exarchou S; Wallman JK; Di Giuseppe D; Klingberg E; Sigurdardottir V; Wedrén S; Lindström U; Turesson C; Jacobsson LTH; Askling J
• Article: AMERICAN HEART JOURNAL. 2023;259:42-51

  Associations between rheumatoid arthritis, incident heart failure, and left ventricular ejection fraction.

  Faxén J; Benson L; Mantel Ä; Savarese G; Hage C; Dahlström U; Askling J; Lund LH; Andersson DC
• Article: ANNALS OF THE RHEUMATIC DISEASES. 2023;82(5):601-610

  Safety of biological and targeted synthetic disease-modifying antirheumatic drugs for rheumatoid arthritis as used in clinical practice: results from the ARTIS programme.

  Frisell T; Bower H; Morin M; Baecklund E; Di Giuseppe D; Delcoigne B; Feltelius N; Forsblad-d'Elia H; Lindqvist E; Lindström U; Askling J; ARTIS Study group
• Letter: ANNALS OF THE RHEUMATIC DISEASES. 2023;82(4):e88

  Response to: 'Correspondence on 'Risk of venous thromboembolism in rheumatoid arthritis and its association with disease activity: a nationwide cohort study from Sweden'' by Zervou et al.

  Molander V; Askling J
• Article: SCANDINAVIAN JOURNAL OF RHEUMATOLOGY. 2023;52(2):111-117

  Validation and characterization of venous thromboembolism diagnoses in the Swedish National Patient Register among patients with rheumatoid arthritis.

  Molander V; Bower H; Askling J
• Article: RMD OPEN. 2023;9(1):e002924

  Exposure to specific tumour necrosis factor inhibitors and risk of demyelinating and inflammatory neuropathy in cohorts of patients with inflammatory arthritis: a collaborative observational study across five Nordic rheumatology registers.

  Delcoigne B; Kopp TI; Arkema EV; Hellgren K; Provan SA; Relas H; Aaltonen K; Trokovic N; Gudbjornsson B; Grondal G; Klami Kristianslund E; Lindhardsen J; Dreyer L; Askling J
• Article: RHEUMATOLOGY. 2023;62(2):647-658

  Is the risk of infection higher during treatment with secukinumab than with TNF inhibitors? An observational study from the Nordic countries.

  Glintborg B; Di Giuseppe D; Wallman JK; Provan SA; Nordström D; Hokkanen A-M; Österlund J; Kristianslund E; Kvien TK; Gudbjornsson B; Hetland ML; Michelsen B; Jacobsson L; Askling J; Lindström U
• Article: JOURNAL OF INTERNAL MEDICINE. 2023;293(2):246-258

  Post COVID-19 condition diagnosis: A population-based cohort study of occurrence, associated factors, and healthcare use by severity of acute infection.

  Hedberg P; Granath F; Bruchfeld J; Askling J; Sjöholm D; Fored M; Färnert A; Naucler P
• Corrigendum: SEMINARS IN ARTHRITIS AND RHEUMATISM. 2023;58:152141

  Corrigendum to 'Predictors of ASDAS-CRP inactive disease in axial spondyloarthritis during treatment with TNF-inhibitors: data from the EuroSpA collaboration' [Seminars in Arthritis and Rheumatism 56 (2022) 1-13/152081].

  Ørnbjerg LM; Linde L; Georgiadis S; Rasmussen SH; Lindström U; Askling J; Michelsen B; Giuseppe DD; Wallman JK; Pavelka K; Závada J; Nissen MJ; Jones GT; Relas H; Pirilä L; Tomšič M; Rotar Z; Geirsson AJ; Gudbjornsson B; Kristianslund EK; van der Horst-Bruinsma I; Loft AG; Laas K; Iannone F; Corrado A; Ciurea A; Santos MJ; Santos H; Codreanu C; Akkoc N; Gunduz OS; Glintborg B; Østergaard M; Hetland ML
• Article: RHEUMATOLOGY AND THERAPY. 2023;10(1):201-223

  Evaluation of VTE, MACE, and Serious Infections Among Patients with RA Treated with Baricitinib Compared to TNFi: A Multi-Database Study of Patients in Routine Care Using Disease Registries and Claims Databases.

  Salinas CA; Louder A; Polinski J; Zhang TC; Bower H; Phillips S; Song Y; Rashidi E; Bosan R; Chang H-C; Foster N; Gershenson B; Yamanaka H; Kishimoto M; Tanaka Y; Fischer P; Zhu B; Faries D; Mai X; Doherty BT; Grelaud A; Thurin NH; Askling J; Deberdt W; B023 Study Consortium
• Article: ANNALS OF THE RHEUMATIC DISEASES. 2023;82(2):189-197

  Venous thromboembolism with JAK inhibitors and other immune-modulatory drugs: a Swedish comparative safety study among patients with rheumatoid arthritis.

  Molander V; Bower H; Frisell T; Delcoigne B; Di Giuseppe D; Askling J; ARTIS study group
• Article: RMD OPEN. 2023;9(1):e002753

  Occurrence and relative risks for non-vertebral fractures in patients with ankylosing spondylitis compared with the general population: a register-based study from Sweden.

  Bengtsson K; Askling J; Lorentzon M; Rosengren B; Deminger A; Klingberg E; Jacobsson L; Forsblad-d'Elia H
• Article: RMD OPEN. 2022;8(2):e002700

  Comorbidities and treatment patterns in early rheumatoid arthritis: a nationwide Swedish study.

  Tidblad L; Westerlind H; Delcoigne B; Askling J; Saevarsdottir S
• Article: AMERICAN JOURNAL OF GASTROENTEROLOGY. 2022;117(12):1971-1981

  Risk of Juvenile Idiopathic Arthritis and Rheumatoid Arthritis in Patients With Celiac Disease: A Population-Based Cohort Study.

  Doyle JB; Lebwohl B; Askling J; Forss A; Green PHR; Roelstraete B; Söderling J; Ludvigsson JF
• Article: RMD OPEN. 2022;8(2):e002776

  Haematological malignancies in patients with psoriatic arthritis overall and treated with TNF inhibitors: a Nordic cohort study.

  Cordtz RL; Askling J; Delcoigne B; Smedby KE; Baecklund E; Ballegaard C; Isomäki P; Aaltonen K; Gudbjornsson B; Love TJ; Provan SA; Michelsen B; Sexton J; Dreyer L; Hellgren K
• Corrigendum: RHEUMATOLOGY. 2022;61(12):4998

  Correction to: Do patient-reported measures of disease activity in rheumatoid arthritis vary between countries? Results from a Nordic collaboration.

  Delcoigne B; Provan SA; Hammer HB; Di Giuseppe D; Frisell T; Glintborg B; Grondal G; Gudbjornsson B; Hetland ML; Michelsen B; Nordström D; Relas H; Askling J
• Article: RHEUMATOLOGY. 2022;61(12):4741-4751

  The impact of a csDMARD in combination with a TNF inhibitor on drug retention and clinical remission in axial spondyloarthritis.

  Nissen M; Delcoigne B; Di Giuseppe D; Jacobsson L; Hetland ML; Ciurea A; Nekvindova L; Iannone F; Akkoc N; Sokka-Isler T; Fagerli KM; Santos MJ; Codreanu C; Pombo-Suarez M; Rotar Z; Gudbjornsson B; van der Horst-Bruinsma I; Loft AG; Möller B; Mann H; Conti F; Yildirim Cetin G; Relas H; Michelsen B; Avila Ribeiro P; Ionescu R; Sanchez-Piedra C; Tomsic M; Geirsson ÁJ; Askling J; Glintborg B; Lindström U
• Article: RHEUMATOLOGY. 2022;61(11):4286-4296

  Do patient-reported measures of disease activity in rheumatoid arthritis vary between countries? Results from a Nordic collaboration.

  Delcoigne B; Provan SA; Hammer HB; Di Giuseppe D; Frisell T; Glintborg B; Grondal G; Gudbjornsson B; Hetland ML; Michelsen B; Nordström D; Relas H; Askling J
• Article: JOURNAL OF CROHNS & COLITIS. 2022;16(10):1540-1550

  Association Between Inflammatory Bowel Disease and Spondyloarthritis: Findings from a Nationwide Study in Sweden.

  Shrestha S; Brand JS; Järås J; Schoultz I; Montgomery S; Askling J; Ludvigsson JF; Olen O; Halfvarson J; SWIBREG Study Group
• Article: RHEUMATOLOGY. 2022;61(10):3952-3962

  Effectiveness of baricitinib and tofacitinib compared with bDMARDs in RA: results from a cohort study using nationwide Swedish register data.

  Barbulescu A; Askling J; Chatzidionysiou K; Forsblad-d'Elia H; Kastbom A; Lindström U; Turesson C; Frisell T
• Article: CLINICAL PHARMACOLOGY & THERAPEUTICS. 2022;112(4):836-845

  Combined Conventional Synthetic Disease Modifying Therapy vs. Infliximab for Rheumatoid Arthritis: Emulating a Randomized Trial in Observational Data.

  Barbulescu A; Askling J; Saevarsdottir S; Kim SC; Frisell T
• Article: JOURNAL OF PEDIATRIC GASTROENTEROLOGY AND NUTRITION. 2022;75(4):480-484

  Colorectal Cancer in Childhood-onset Inflammatory Bowel Disease: A Scandinavian Register-based Cohort Study, 1969-2017.

  Everhov ÅH; Ludvigsson JF; Järås J; Erichsen R; Pedersen L; Halfvarson J; Askling J; Ekbom A; Sørensen HT; Olén O
• Article: ALIMENTARY PHARMACOLOGY & THERAPEUTICS. 2022;56(7):1168-1182

  Colorectal cancer in elderly-onset inflammatory bowel disease: a 1969-2017 Scandinavian register-based cohort study.

  Everhov ÅH; Erichsen R; Järås J; Pedersen L; Halfvarson J; Askling J; Ekbom A; Ludvigsson JF; Sørensen HT; Olén O
• Article: RMD OPEN. 2022;8(2):e002465

  Risk of lung cancer in rheumatoid arthritis and in relation to autoantibody positivity and smoking.

  Chatzidionysiou K; di Giuseppe D; Soderling J; Catrina A; Askling J
• Article: SEMINARS IN ARTHRITIS AND RHEUMATISM. 2022;56:152081

  Predictors of ASDAS-CRP inactive disease in axial spondyloarthritis during treatment with TNF-inhibitors: Data from the EuroSpA collaboration.

  Ørnbjerg LM; Linde L; Georgiadis S; Rasmussen SH; Lindström U; Askling J; Michelsen B; Giuseppe DD; Wallman JK; Pavelka K; Závada J; Nissen MJ; Jones GT; Relas H; Pirilä L; Tomšič M; Rotar Z; Geirsson AJ; Gudbjornsson B; Kristianslund EK; van Sder Horst-Bruinsma I; Loft AG; Laas K; Iannone F; Corrado A; Ciurea A; Santos MJ; Santos H; Codreanu C; Akkoc N; Gunduz OS; Glintborg B; Østergaard M; Hetland ML
• Article: RHEUMATOLOGY. 2022;61(9):3799-3807

  European bio-naïve spondyloarthritis patients initiating TNF inhibitor: time trends in baseline characteristics, treatment retention and response.

  Christiansen SN; Ørnbjerg LM; Rasmussen SH; Loft AG; Askling J; Iannone F; Zavada J; Michelsen B; Nissen M; Onen F; Santos MJ; Pombo-Suarez M; Relas H; Macfarlane GJ; Tomsic M; Codreanu C; Gudbjornsson B; Van der Horst-Bruinsma I; Di Giuseppe D; Glintborg B; Gremese E; Pavelka K; Kristianslund EK; Ciurea A; Akkoc N; Barcelos A; Sánchez-Piedra C; Peltomaa R; Jones GT; Rotar Z; Ionescu R; Grondal G; Van de Sande MGH; Laas K; Østergaard M; Hetland ML
• Article: RHEUMATOLOGY. 2022;61(9):3647-3656

  The occurrence of multiple treatment switches in axial spondyloarthritis. Results from five Nordic rheumatology registries.

  Di Giuseppe D; Lindström U; Aaltonen K; Relas H; Provan S; Gudbjornsson B; Hetland ML; Askling J; Kauppi M; Geirsson AJ; Chatzidionysiou K; Jørgensen TS; Dreyer L; Michelsen B; Jacobsson L; Glintborg B
• Article: RHEUMATOLOGY. 2022;61(9):3596-3605

  Comparison of treatment retention of originator vs biosimilar products in clinical rheumatology practice in Sweden.

  Di Giuseppe D; Lindstrom U; Bower H; Delcoigne B; Frisell T; Chatzidionysiou K; Sjöwall C; Lindqvist E; Askling J
• Article: ARTHRITIS RESEARCH & THERAPY. 2022;24(1):203

  Neither low social support nor low decision latitude at work is associated with disease remission among patients with rheumatoid arthritis: results from the Swedish EIRA study.

  Hedenstierna L; Hedström AK; Klareskog L; Di Giuseppe D; Alfredsson L; Askling J; Ernestam S; Saevarsdottir S; Ljung L
• Article: ARTHRITIS RESEARCH & THERAPY. 2022;24(1):185

  Does persistence to methotrexate treatment in early rheumatoid arthritis have a familial component?

  Sysojev AÖ; Frisell T; Delcoigne B; Saevarsdottir S; Askling J; Westerlind H
• Article: ALIMENTARY PHARMACOLOGY & THERAPEUTICS. 2022;56(3):491-500

  Age determines the risk of familial inflammatory bowel disease-A nationwide study.

  Halfvarson J; Ludvigsson JF; Bresso F; Askling J; Sachs MC; Olén O
• Article: ANNALS OF THE RHEUMATIC DISEASES. 2022;81(8):1085-1095

  Multiomics analysis of rheumatoid arthritis yields sequence variants that have large effects on risk of the seropositive subset.

  Saevarsdottir S; Stefansdottir L; Sulem P; Thorleifsson G; Ferkingstad E; Rutsdottir G; Glintborg B; Westerlind H; Grondal G; Loft IC; Sorensen SB; Lie BA; Brink M; Ärlestig L; Arnthorsson AO; Baecklund E; Banasik K; Bank S; Bjorkman LI; Ellingsen T; Erikstrup C; Frei O; Gjertsson I; Gudbjartsson DF; Gudjonsson SA; Halldorsson GH; Hendricks O; Hillert J; Hogdall E; Jacobsen S; Jensen DV; Jonsson H; Kastbom A; Kockum I; Kristensen S; Kristjansdottir H; Larsen MH; Linauskas A; Hauge E-M; Loft AG; Ludviksson BR; Lund SH; Markusson T; Masson G; Melsted P; Moore KHS; Munk H; Nielsen KR; Norddahl GL; Oddsson A; Olafsdottir TA; Olason PI; Olsson T; Ostrowski SR; Hørslev-Petersen K; Rognvaldsson S; Sanner H; Silberberg GN; Stefansson H; Sørensen E; Sørensen IJ; Turesson C; Bergman T; Alfredsson L; Kvien TK; Brunak S; Steinsson K; Andersen V; Andreassen OA; Rantapää-Dahlqvist S; Hetland ML; Klareskog L; Askling J; Padyukov L; Pedersen OB; Thorsteinsdottir U; Jonsdottir I; Stefansson K; Members of the DBDS Genomic Consortium; Danish RA Genetics Working Group; Swedish Rheumatology Quality Register Biobank Stud
• Article: ANNALS OF THE RHEUMATIC DISEASES. 2022;81(6):789-797

  Short-term, intermediate-term and long-term risks of acute coronary syndrome in cohorts of patients with RA starting biologic DMARDs: results from four Nordic countries.

  Delcoigne B; Ljung L; Provan SA; Glintborg B; Hetland ML; Grøn KL; Peltomaa R; Relas H; Turesson C; Gudbjornsson B; Michelsen B; Askling J
• Article: RHEUMATOLOGY. 2022;61(5):1810-1818

  Short- and longer-term cancer risks with biologic and targeted synthetic disease-modifying antirheumatic drugs as used against rheumatoid arthritis in clinical practice.

  Huss V; Bower H; Wadström H; Frisell T; Askling J; ARTIS group
• Letter: ANNALS OF THE RHEUMATIC DISEASES. 2022;81(5):e74

  Response to: 'Neuroinflammatory events after anti-TNFα therapy' by Kaltsonoudis et al.

  Kopp TI; Delcoigne B; Arkema EV; Magyari M; Locht H; Sellebjerg FT; Cordtz RL; Jensen DV; Askling J; Dreyer L
• Article: ARTHRITIS CARE & RESEARCH. 2022;74(5):748-758

  One-Year Treatment Outcomes of Secukinumab Versus Tumor Necrosis Factor Inhibitors in Spondyloarthritis: Results From Five Nordic Biologic Registries Including More Than 10,000 Treatment Courses.

  Glintborg B; Lindström U; Giuseppe DD; Provan SA; Gudbjornsson B; Hetland ML; Michelsen B; Wallman JK; Aaltonen K; Hokkanen A-M; Nordström D; Jørgensen TS; Hansen RL; Geirsson AJ; Grøn KL; Krogh NS; Askling J; Kristensen LE; Jacobsson LTH; Danish Rheumatology Database (DANBIO), Anti-Rheuma
• Article: RHEUMATOLOGY. 2022;61(3):1228-1232

  Juvenile idiopathic arthritis, marriage and parenthood: a nationwide matched cohort study.

  Bruze G; Askling J; Horne A; Neovius M
• Article: ANNALS OF THE RHEUMATIC DISEASES. 2022;81(3):433-439

  Influenza outcomes in patients with inflammatory joint diseases and DMARDs: how do they compare to those of COVID-19?

  Bower H; Frisell T; Di Giuseppe D; Delcoigne B; Askling J
• Article: HEART. 2022;108(6):467-473

  Risk and predictors of heart failure in sarcoidosis in a population-based cohort study from Sweden.

  Rossides M; Kullberg S; Grunewald J; Eklund A; Di Giuseppe D; Askling J; Arkema EV
• Article: RMD OPEN. 2022;8(1):e002018

  Allergic conditions and risk of rheumatoid arthritis: a Swedish case-control study.

  Kronzer VL; Westerlind H; Alfredsson L; Crowson CS; Klareskog L; Holmqvist M; Askling J
• Letter: RHEUMATOLOGY. 2021;61(1):e31

  Comment on: Incidence of extra-articular manifestations in AS, PsA and undifferentiated SpA: results from a national register-based cohort study. Reply.

  Bengtsson K; Forsblad-d'Elia H; Deminger A; Klingberg E; Dehlin M; Exarchou S; Lindström U; Askling J; Jacobsson LTH
• Article: RMD OPEN. 2021;7(3):e001987

  Effects of the COVID-19 pandemic on patients with inflammatory joint diseases in Sweden: from infection severity to impact on care provision.

  Bower H; Frisell T; di Giuseppe D; Delcoigne B; Ahlenius G-M; Baecklund E; Chatzidionysiou K; Feltelius N; Forsblad-d'Elia H; Kastbom A; Klareskog L; Lindqvist E; Lindström U; Turesson C; Sjowall C; Askling J; ARTIS Study Group
• Article: RESPIRATORY MEDICINE. 2021;188:106624

  Risk of acute myocardial infarction in sarcoidosis: A population-based cohort study from Sweden.

  Rossides M; Kullberg S; Grunewald J; Eklund A; Di Giuseppe D; Askling J; Arkema EV
• Article: ANNALS OF THE RHEUMATIC DISEASES. 2021;80(11):1410-1418

  Effectiveness and treatment retention of TNF inhibitors when used as monotherapy versus comedication with csDMARDs in 15 332 patients with psoriatic arthritis. Data from the EuroSpA collaboration.

  Lindström U; Di Giuseppe D; Delcoigne B; Glintborg B; Möller B; Ciurea A; Pombo-Suarez M; Sanchez-Piedra C; Eklund K; Relas H; Gudbjornsson B; Love TJ; Jones GT; Codreanu C; Ionescu R; Nekvindova L; Závada J; Atas N; Yolbas S; Fagerli KM; Michelsen B; Rotar Ž; Tomšič M; Iannone F; Santos MJ; Avila-Ribeiro P; Ørnbjerg LM; Østergaard M; Jacobsson LT; Askling J; Nissen MJ
• Article: ANNALS OF THE RHEUMATIC DISEASES. 2021;80(11):1445-1452

  Anterior uveitis in patients with spondyloarthritis treated with secukinumab or tumour necrosis factor inhibitors in routine care: does the choice of biological therapy matter?

  Lindström U; Bengtsson K; Olofsson T; Di Giuseppe D; Glintborg B; Forsblad-d'Elia H; Jacobsson LTH; Askling J
• Article: SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY. 2021;56(10):1152-1162

  Adult-onset inflammatory bowel disease and rate of serious infections compared to the general population: a nationwide register-based cohort study 2002-2017.

  Ludvigsson JF; Holmgren J; Grip O; Halfvarson J; Askling J; Sachs MC; Olén O
• Article: JOURNAL OF RHEUMATOLOGY. 2021;48(10):1512-1518

  Effectiveness of a Second Biologic After Failure of a Non-tumor Necrosis Factor Inhibitor As First Biologic in Rheumatoid Arthritis.

  Chatzidionysiou K; Hetland ML; Frisell T; Di Giuseppe D; Hellgren K; Glintborg B; Nordström D; Peltomaa R; Aaltonen K; Trokovic N; Kristianslund EK; Kvien TK; Provan SA; Gudbjornsson B; Grondal G; Dreyer L; Kristensen LE; Jørgensen TS; Jacobsson LTH; Askling J
• Article: RHEUMATOLOGY. 2021;60(8):3760-3769

  Comorbidities at diagnosis of rheumatoid arthritis: a population-based case-control study.

  Tidblad L; Westerlind H; Delcoigne B; Askling J; Saevarsdottir S
• Article: RHEUMATOLOGY. 2021;60(8):3656-3668

  Risk of solid cancers overall and by subtypes in patients with psoriatic arthritis treated with TNF inhibitors - a Nordic cohort study.

  Hellgren K; Ballegaard C; Delcoigne B; Cordtz R; Nordström D; Aaltonen K; Gudbjornsson B; Love TJ; Aarrestad Provan S; Sexton J; Zobbe K; Kristensen LE; Askling J; Dreyer L
• Article: RHEUMATOLOGY. 2021;60(8):3635-3645

  Comparison of treatment retention and response to secukinumab versus tumour necrosis factor inhibitors in psoriatic arthritis.

  Lindström U; Glintborg B; Di Giuseppe D; Schjødt Jørgensen T; Gudbjornsson B; Lederballe Grøn K; Aarrestad Provan S; Michelsen B; Lund Hetland M; Wallman JK; Nordström D; Trokovic N; Love TJ; Krogh NS; Askling J; Jacobsson LTH; Kristensen LE
• Article: ANNALS OF THE RHEUMATIC DISEASES. 2021;80(8):1086-1093

  Impact of the COVID-19 pandemic on morbidity and mortality in patients with inflammatory joint diseases and in the general population: a nationwide Swedish cohort study.

  Bower H; Frisell T; Di Giuseppe D; Delcoigne B; Ahlenius G-M; Baecklund E; Chatzidionysiou K; Feltelius N; Forsblad-d'Elia H; Kastbom A; Klareskog L; Lindqvist E; Lindström U; Turesson C; Sjöwall C; Askling J; ARTIS Study Group
• Article: JOURNAL OF RHEUMATOLOGY. 2021;48(8):1243-1250

  Tuberculosis in Biologic-naïve Patients With Rheumatoid Arthritis: Risk Factors and Tuberculosis Characteristics.

  Sundbaum JK; Arkema EV; Bruchfeld J; Jonsson J; Askling J; Baecklund E
• Article: CLINICAL AND EXPERIMENTAL RHEUMATOLOGY. 2021;39(4):879-882

  Rheumatoid arthritis autoantibodies and their association with age and sex.

  Pertsinidou E; Manivel VA; Westerlind H; Klareskog L; Alfredsson L; Mathsson-Alm L; Hansson M; Saevarsdottir S; Askling J; Rönnelid J
• Article: ACR OPEN RHEUMATOLOGY. 2021;3(7):457-463

  What Is the Persistence to Methotrexate in Rheumatoid Arthritis, and Does Machine Learning Outperform Hypothesis-Based Approaches to Its Prediction?

  Westerlind H; Maciejewski M; Frisell T; Jelinsky SA; Ziemek D; Askling J
• Article: JOURNAL OF CROHNS & COLITIS. 2021;15(6):980-987

  Women's Earnings are more Affected by Inflammatory Bowel Disease than Men's: A Register-Based Swedish Cohort Study.

  Everhov ÅH; Bruze G; Söderling J; Askling J; Halfvarson J; Westberg K; Malmborg P; Nordenvall C; Ludvigsson JF; Olén O
• Article: RHEUMATOLOGY. 2021;60(6):2725-2734

  Incidence of extra-articular manifestations in ankylosing spondylitis, psoriatic arthritis and undifferentiated spondyloarthritis: results from a national register-based cohort study.

  Bengtsson K; Forsblad-d'Elia H; Deminger A; Klingberg E; Dehlin M; Exarchou S; Lindström U; Askling J; Jacobsson LTH
• Article: RHEUMATOLOGY. 2021;60(5):2217-2222

  Mortality over 14 years in MTX-refractory patients randomized to a strategy of addition of infliximab or sulfasalazine and hydroxychloroquine.

  Miller H; Wallman JK; Petersson IF; Saevarsdottir S; Söderling J; Ernestam S; Askling J; van Vollenhoven R; Neovius M
• Article: SCANDINAVIAN JOURNAL OF RHEUMATOLOGY. 2021;50(3):178-182

  Social stressors and risk of rheumatoid arthritis and their relationship to known modifiable risk factors: results from the Swedish EIRA study.

  Hedenstierna L; Opava CH; Askling J; Jiang X; Ernestam S; Alfredsson L; Klareskog L; Saevarsdottir S
• Article: CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION. 2021;30(5):886-894

  Hepatobiliary Cancer Risk in Patients with Inflammatory Bowel Disease: A Scandinavian Population-Based Cohort Study.

  Erichsen R; Olén O; Sachs MC; Pedersen L; Halfvarson J; Askling J; Ekbom A; Ludvigsson JF; Sørensen HT
• Letter: GUT. 2021;70(5):998

  Reply: Survival in Crohn's disease-associated small bowel adenocarcinoma.

  Axelrad JE; Olén O; Sachs MC; Erichsen R; Pedersen L; Halfvarson J; Askling J; Ekbom A; Sørensen HT; Ludvigsson JF
• Article: RESPIROLOGY. 2021;26(5):452-460

  Infection risk in sarcoidosis patients treated with methotrexate compared to azathioprine: A retrospective 'target trial' emulated with Swedish real-world data.

  Rossides M; Kullberg S; Di Giuseppe D; Eklund A; Grunewald J; Askling J; Arkema EV
• Article: ARTHRITIS CARE & RESEARCH. 2021;73(5):658-665

  Findings on Coronary Angiographies in Patients With Rheumatoid Arthritis and Ischemic Heart Disease: Are They Different From Patients Without Rheumatoid Arthritis?

  Holmqvist M; Mantel Ä; Wållberg-Jonsson S; James S; Jernberg T; Askling J
• Article: CLINICAL RHEUMATOLOGY. 2021;40(4):1321-1329

  Characteristics and outcome of a first acute myocardial infarction in patients with ankylosing spondylitis.

  Södergren A; Askling J; Bengtsson K; Forsblad-d'Elia H; Jernberg T; Lindström U; Ljung L; Mantel Ä; Jacobsson LTH
• Article: LIVER INTERNATIONAL. 2021;41(3):545-553

  Morbidity, risk of cancer and mortality in 3645 HFE mutations carriers.

  Hagström H; Ndegwa N; Jalmeus M; Ekstedt M; Posserud I; Rorsman F; Nyhlin N; Klintman D; Werner M; Marschall H-U; Askling J; Stål P; Swedish Hepatology Study Group (SweHep)
• Article: GUT. 2021;70(2):297-308

  Inflammatory bowel disease and risk of small bowel cancer: a binational population-based cohort study from Denmark and Sweden.

  Axelrad JE; Olén O; Sachs MC; Erichsen R; Pedersen L; Halfvarson J; Askling J; Ekbom A; Sørensen HT; Ludvigsson JF
• Article: RHEUMATOLOGY. 2021;60(2):820-828

  The impact of seropositivity on the effectiveness of biologic anti-rheumatic agents: results from a collaboration of 16 registries.

  Courvoisier DS; Chatzidionysiou K; Mongin D; Lauper K; Mariette X; Morel J; Gottenberg J-E; Bergstra SA; Suarez MP; Codreanu C; Kvien TK; Santos MJ; Pavelka K; Hetland ML; Askling J; Turesson C; Kubo S; Tanaka Y; Iannone F; Choquette D; Nordström DC; Rotar Z; Lukina G; Gabay C; Van Vollenhoven R; Finckh A
• Article: RHEUMATOLOGY. 2021;60(2):809-819

  Lymphoma risks in patients with rheumatoid arthritis treated with biological drugs-a Swedish cohort study of risks by time, drug and lymphoma subtype.

  Hellgren K; Di Giuseppe D; Smedby KE; Sundström C; Askling J; Baecklund E; ARTIS study group
• Article: ANNALS OF THE RHEUMATIC DISEASES. 2021;80(2):169-175

  Risk of venous thromboembolism in rheumatoid arthritis, and its association with disease activity: a nationwide cohort study from Sweden.

  Molander V; Bower H; Frisell T; Askling J
• Article: RHEUMATOLOGY. 2021;60(1):140-146

  Inflammatory hallmarks of lesser prominence in psoriatic arthritis patients starting biologics: a Nordic population-based cohort study.

  Lund Hansen R; Schoedt Jørgensen T; Dreyer L; Hetland ML; Glintborg B; Askling J; Di Giuseppe D; Jacobsson LTH; Wallman JK; Nordstrom D; Aaltonen K; Kristianslund EK; Kvien TK; Provan SA; Gudbjornsson B; Love TJ; Kristensen LE
• Article: CLINICAL EPIDEMIOLOGY. 2021;13:21-41

  Adaptation of the Charlson Comorbidity Index for Register-Based Research in Sweden.

  Ludvigsson JF; Appelros P; Askling J; Byberg L; Carrero J-J; Ekström AM; Ekström M; Smedby KE; Hagström H; James S; Järvholm B; Michaelsson K; Pedersen NL; Sundelin H; Sundquist K; Sundström J
• Article: ARTHRITIS & RHEUMATOLOGY. 2021;73(1):61-68

  Respiratory Diseases as Risk Factors for Seropositive and Seronegative Rheumatoid Arthritis and in Relation to Smoking.

  Kronzer VL; Westerlind H; Alfredsson L; Crowson CS; Nyberg F; Tornling G; Klareskog L; Holmqvist M; Askling J
• Article: EUROPEAN JOURNAL OF HAEMATOLOGY. 2020;105(6):779-785

  Concordance in survival among first-degree relatives diagnosed with indolent lymphoid malignancies including chronic lymphocytic leukemia.

  Baecklund F; Ekberg S; Rosenquist R; Askling J; Eloranta S; Smedby KE
• Article: RMD OPEN. 2020;6(3):e001463

  Is rheumatoid arthritis a risk factor for acute coronary syndrome also among individuals at elevated risk, such as individuals presenting with acute chest pain?

  Svensson P; Bergstrom M; Discacciati A; Ljung L; Jernberg T; Frick M; Linder R; Askling J
• Article: EUROPEAN JOURNAL OF EPIDEMIOLOGY. 2020;35(11):1087-1097

  Are infectious diseases risk factors for sarcoidosis or a result of reverse causation? Findings from a population-based nested case-control study.

  Rossides M; Kullberg S; Askling J; Eklund A; Grunewald J; Di Giuseppe D; Arkema EV
• Article: SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY. 2020;55(10):1205-1210

  Validity of administrative codes associated with cirrhosis in Sweden.

  Bengtsson B; Askling J; Ludvigsson JF; Hagström H
• Article: ARTHRITIS & RHEUMATOLOGY. 2020;72(10):1658-1667

  Anti-Citrullinated Protein Antibody Specificities, Rheumatoid Factor Isotypes, and Incident Cardiovascular Events in Patients With Rheumatoid Arthritis.

  Westerlind H; Rönnelid J; Hansson M; Alfredsson L; Mathsson-Alm L; Serre G; Cornillet M; Holmdahl R; Jakobsson P-J; Skriner K; Klareskog L; Saevarsdottir S; Askling J
• Article: RMD OPEN. 2020;6(3):e001280

  Drug retention, inactive disease and response rates in 1860 patients with axial spondyloarthritis initiating secukinumab treatment: routine care data from 13 registries in the EuroSpA collaboration.

  Michelsen B; Lindström U; Codreanu C; Ciurea A; Zavada J; Loft AG; Pombo-Suarez M; Onen F; Kvien TK; Rotar Z; Santos MJ; Iannone F; Hokkanen A-M; Gudbjornsson B; Askling J; Ionescu R; Nissen MJ; Pavelka K; Sanchez-Piedra C; Akar S; Sexton J; Tomsic M; Santos H; Sebastiani M; Österlund J; Geirsson AJ; Macfarlane G; van der Horst-Bruinsma I; Georgiadis S; Brahe CH; Ørnbjerg LM; Hetland ML; Østergaard M
• Article: RMD OPEN. 2020;6(2):e001363

  How do we use biologics in rheumatoid arthritis patients with a history of malignancy? An assessment of treatment patterns using Scandinavian registers.

  Chatzidionysiou K; Delcoigne B; Frisell T; Hetland ML; Glintborg B; Dreyer L; Cordtz R; Zobbe K; Nordström D; Trokovic N; Aaltonen K; Provan SA; Grondal G; Gudbjornsson B; Askling J
• Article: EUROPEAN RESPIRATORY JOURNAL. 2020;56(3):2000767

  Risk of first and recurrent serious infection in sarcoidosis: a Swedish register-based cohort study.

  Rossides M; Kullberg S; Eklund A; Di Giuseppe D; Grunewald J; Askling J; Arkema EV
• Article: RHEUMATOLOGY. 2020;59(9):2455-2461

  Impact of discordance between patient's and evaluator's global assessment on treatment outcomes in 14 868 patients with spondyloarthritis.

  Michelsen B; Ørnbjerg LM; Kvien TK; Pavelka K; Nissen MJ; Nordström D; Santos MJ; Koca SS; Askling J; Rotar Z; Gudbjornsson B; Codreanu C; Loft AG; Kristianslund EK; Mann HF; Ciurea A; Eklund KK; Vieira-Sousa E; Yazici A; Jacobsson L; Tomšič M; Löve TJ; Ionescu R; van der Horst-Bruinsma IE; Iannone F; Pombo-Suarez M; Jones GT; Hyldstrup LH; Krogh NS; Hetland ML; Østergaard M
• Article: NATURE. 2020;584(7822):619-623

  FLT3 stop mutation increases FLT3 ligand level and risk of autoimmune thyroid disease.

  Saevarsdottir S; Olafsdottir TA; Ivarsdottir EV; Halldorsson GH; Gunnarsdottir K; Sigurdsson A; Johannesson A; Sigurdsson JK; Juliusdottir T; Lund SH; Arnthorsson AO; Styrmisdottir EL; Gudmundsson J; Grondal GM; Steinsson K; Alfredsson L; Askling J; Benediktsson R; Bjarnason R; Geirsson AJ; Gudbjornsson B; Gudjonsson H; Hjaltason H; Hreidarsson AB; Klareskog L; Kockum I; Kristjansdottir H; Love TJ; Ludviksson BR; Olsson T; Onundarson PT; Orvar KB; Padyukov L; Sigurgeirsson B; Tragante V; Bjarnadottir K; Rafnar T; Masson G; Sulem P; Gudbjartsson DF; Melsted P; Thorleifsson G; Norddahl GL; Thorsteinsdottir U; Jonsdottir I; Stefansson K
• Article: ALIMENTARY PHARMACOLOGY & THERAPEUTICS. 2020;52(4):655-668

  Healthcare use, work loss and total costs in incident and prevalent Crohn's disease and ulcerative colitis: results from a nationwide study in Sweden.

  Khalili H; Everhov ÅH; Halfvarson J; Ludvigsson JF; Askling J; Myrelid P; Söderling J; Olen O; Neovius M; SWIBREG Group
• Article: ALIMENTARY PHARMACOLOGY & THERAPEUTICS. 2020;52(1):143-154

  Inflammatory bowel disease and pancreatic cancer: a Scandinavian register-based cohort study 1969-2017.

  Everhov ÅH; Erichsen R; Sachs MC; Pedersen L; Halfvarson J; Askling J; Ekbom A; Ludvigsson JF; Sørensen HT; Olén O
• Article: RMD OPEN. 2020;6(2):e001282

  Does autoimmune thyroid disease affect rheumatoid arthritis disease activity or response to methotrexate?

  Waldenlind K; Delcoigne B; Saevarsdottir S; Askling J
• Article: RMD OPEN. 2020;6(2):e001201

  Gastrointestinal perforations in patients with rheumatoid arthritis treated with biological disease-modifying antirheumatic drugs in Sweden: a nationwide cohort study.

  Barbulescu A; Delcoigne B; Askling J; Frisell T
• Review: ANNALS OF THE RHEUMATIC DISEASES. 2020;79(6):685-699

  EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs: 2019 update.

  Smolen JS; Landewé RBM; Bijlsma JWJ; Burmester GR; Dougados M; Kerschbaumer A; McInnes IB; Sepriano A; van Vollenhoven RF; de Wit M; Aletaha D; Aringer M; Askling J; Balsa A; Boers M; den Broeder AA; Buch MH; Buttgereit F; Caporali R; Cardiel MH; De Cock D; Codreanu C; Cutolo M; Edwards CJ; van Eijk-Hustings Y; Emery P; Finckh A; Gossec L; Gottenberg J-E; Hetland ML; Huizinga TWJ; Koloumas M; Li Z; Mariette X; Müller-Ladner U; Mysler EF; da Silva JAP; Poór G; Pope JE; Rubbert-Roth A; Ruyssen-Witrand A; Saag KG; Strangfeld A; Takeuchi T; Voshaar M; Westhovens R; van der Heijde D
• Article: SCANDINAVIAN JOURNAL OF RHEUMATOLOGY. 2020;49(3):225-232

  Population-based study of patients with primary Sjögren's syndrome and lymphoma: lymphoma subtypes, clinical characteristics, and gender differences.

  Vasaitis L; Nordmark G; Theander E; Backlin C; Smedby KE; Askling J; Rönnblom L; Sundström C; Baecklund E
• Article: ANNALS OF THE RHEUMATIC DISEASES. 2020;79(5):566-572

  Risk of neuroinflammatory events in arthritis patients treated with tumour necrosis factor alpha inhibitors: a collaborative population-based cohort study from Denmark and Sweden.

  Kopp TI; Delcoigne B; Arkema EV; Jacobsen RK; Magyari M; Ibfelt EH; Locht H; Sellebjerg F; Cordtz RL; Jensen DV; Askling J; Dreyer L
• Article: LANCET GASTROENTEROLOGY & HEPATOLOGY. 2020;5(5):475-484

  Colorectal cancer in Crohn's disease: a Scandinavian population-based cohort study.

  Olén O; Erichsen R; Sachs MC; Pedersen L; Halfvarson J; Askling J; Ekbom A; Sørensen HT; Ludvigsson JF
• Article: ANNALS OF NEUROLOGY. 2020;87(5):688-699

  Cancer Risk for Fingolimod, Natalizumab, and Rituximab in Multiple Sclerosis Patients.

  Alping P; Askling J; Burman J; Fink K; Fogdell-Hahn A; Gunnarsson M; Hillert J; Langer-Gould A; Lycke J; Nilsson P; Salzer J; Svenningsson A; Vrethem M; Olsson T; Piehl F; Frisell T
• Letter: ANNALS OF THE RHEUMATIC DISEASES. 2020;79(5):e50

  Response to: 'Inflammatory and non-inflammatory triggers of acute coronary syndromes' by Eyuboglu.

  Westerlind H; Holmqvist M; Ljung L; Frisell T; Askling J
• Article: RMD OPEN. 2020;6(1):e001197

  Siblings of patients with rheumatoid arthritis have an increased mortality rate: a Swedish cohort study.

  Westerlind H; Delcoigne B; Askling J
• Article: ANNALS OF THE RHEUMATIC DISEASES. 2020;79(5):581-586

  Risk of breast cancer before and after rheumatoid arthritis, and the impact of hormonal factors.

  Wadström H; Pettersson A; Smedby KE; Askling J
• Article: ALIMENTARY PHARMACOLOGY & THERAPEUTICS. 2020;51(8):789-800

  Adult height in patients with childhood-onset inflammatory bowel disease: a nationwide population-based cohort study.

  Mouratidou N; Malmborg P; Sachs MC; Askling J; Ekbom A; Neovius M; Smedby KE; Sävendahl L; Ludvigsson JF; Olén O
• Article: GUT. 2020;69(3):453-461

  Mortality in adult-onset and elderly-onset IBD: a nationwide register-based cohort study 1964-2014.

  Olén O; Askling J; Sachs MC; Neovius M; Smedby KE; Ekbom A; Ludvigsson JF
• Article: LANCET. 2020;395(10218):123-131

  Colorectal cancer in ulcerative colitis: a Scandinavian population-based cohort study.

  Olén O; Erichsen R; Sachs MC; Pedersen L; Halfvarson J; Askling J; Ekbom A; Sørensen HT; Ludvigsson JF
• Article: CLINICAL EPIDEMIOLOGY. 2020;12:273-285

  Work Loss in Relation to Pharmacological and Surgical Treatment for Crohn's Disease: A Population-Based Cohort Study.

  Everhov ÅH; Sachs MC; Ludvigsson JF; Khalili H; Askling J; Neovius M; Myrelid P; Halfvarson J; Nordenvall C; Söderling J; Olén O; SWIBREG study group
• Letter: RESPIRATORY MEDICINE. 2019;160:105696

  Correspondence for "Clinical epidemiology of familial sarcoidosis: A systematic literature review".

  Rossides M; Grunewald J; Eklund A; Kullberg S; Askling J; Arkema EV
• Article: ANNALS OF THE RHEUMATIC DISEASES. 2019;78(11):1536-1544

  Treatment response and drug retention rates in 24 195 biologic-naïve patients with axial spondyloarthritis initiating TNFi treatment: routine care data from 12 registries in the EuroSpA collaboration.

  Ørnbjerg LM; Brahe CH; Askling J; Ciurea A; Mann H; Onen F; Kristianslund EK; Nordström D; Santos MJ; Codreanu C; Gómez-Reino J; Rotar Z; Gudbjornsson B; Di Giuseppe D; Nissen MJ; Pavelka K; Birlik M; Kvien T; Eklund KK; Barcelos A; Ionescu R; Sanchez-Piedra C; Tomsic M; Geirsson ÁJ; Loft AG; van der Horst-Bruinsma I; Jones G; Iannone F; Hyldstrup L; Krogh NS; Hetland ML; Østergaard M
• Article: INFLAMMATORY BOWEL DISEASES. 2019;25(10):1663-1673

  Effects of Childhood-onset Inflammatory Bowel Disease on School Performance: A Nationwide Population-based Cohort Study Using Swedish Health and Educational Registers.

  Malmborg P; Mouratidou N; Sachs MC; Hammar U; Khalili H; Neovius M; Hjern A; Smedby KE; Ekbom A; Askling J; Ludvigsson JF; Olén O
• Review: ANNALS OF THE RHEUMATIC DISEASES. 2019;78(9):1160-1166

  2018 EULAR recommendations for a core data set to support observational research and clinical care in giant cell arteritis.

  Ehlers L; Askling J; Bijlsma HW; Cid MC; Cutolo M; Dasgupta B; Dejaco C; Dixon WG; Feltelius N; Finckh A; Gilbert K; Mackie SL; Mahr A; Matteson EL; Neill L; Salvarani C; Schmidt WA; Strangfeld A; van Vollenhoven RF; Buttgereit F
• Letter: RHEUMATOLOGY. 2019;58(8):1507-1509

  Comment on: Comparative effectiveness of abatacept, rituximab, tocilizumab and TNFi biologics in RA: results from the nationwide Swedish register: reply.

  Frisell T; Askling J
• Letter: RHEUMATOLOGY. 2019;58(8):1510-1511

  Comment on: Comparative effectiveness of abatacept, rituximab, tocilizumab and TNFi biologics in RA: results from the nationwide Swedish register: reply.

  Frisell T; Askling J
• Article: INFLAMMATORY BOWEL DISEASES. 2019;25(7):1237-1247

  Work Loss Before and After Diagnosis of Crohn's Disease.

  Everhov ÅH; Khalili H; Askling J; Myrelid P; Ludvigsson JF; Halfvarson J; Nordenvall C; Neovius M; Söderling J; Olén O
• Article: CLINICAL GASTROENTEROLOGY AND HEPATOLOGY. 2019;17(7):1311-1322.e7

  Gastrointestinal Infection Increases Odds of Inflammatory Bowel Disease in a Nationwide Case-Control Study.

  Axelrad JE; Olén O; Askling J; Lebwohl B; Khalili H; Sachs MC; Ludvigsson JF
• Article: ARTHRITIS RESEARCH & THERAPY. 2019;21(1):128

  Biological treatment of ankylosing spondylitis: a nationwide study of treatment trajectories on a patient level in clinical practice.

  Lindström U; Olofsson T; Wedrén S; Qirjazo I; Askling J
• Article: SCANDINAVIAN JOURNAL OF RHEUMATOLOGY. 2019;48(3):207-212

  Comparison of patients with and without pre-existing lymphoma at diagnosis of primary Sjögren's syndrome.

  Vasaitis L; Nordmark G; Theander E; Backlin C; Smedby KE; Askling J; Rönnblom L; Sundström C; Baecklund E
• Article: ANNALS OF THE RHEUMATIC DISEASES. 2019;78(5):683-687

  Siblings of patients with rheumatoid arthritis are at increased risk of acute coronary syndrome.

  Westerlind H; Holmqvist M; Ljung L; Frisell T; Askling J
• Article: ANNALS OF THE RHEUMATIC DISEASES. 2019;78(3):320-327

  Risk of serious infections in patients with rheumatoid arthritis treated in routine care with abatacept, rituximab and tocilizumab in Denmark and Sweden.

  Grøn KL; Arkema EV; Glintborg B; Mehnert F; Østergaard M; Dreyer L; Nørgaard M; Krogh NS; Askling J; Hetland ML; ARTIS Study Group
• Article: AMERICAN JOURNAL OF GASTROENTEROLOGY. 2019;114(2):291-304

  Fracture Risk in Patients With Inflammatory Bowel Disease: A Nationwide Population-Based Cohort Study From 1964 to 2014.

  Ludvigsson JF; Mahl M; Sachs MC; Björk J; Michaelsson K; Ekbom A; Askling J; Backman A-S; Olén O
• Article: GASTROENTEROLOGY. 2019;156(3):614-622

  Increased Mortality of Patients With Childhood-Onset Inflammatory Bowel Diseases, Compared With the General Population.

  Olén O; Askling J; Sachs MC; Frumento P; Neovius M; Smedby KE; Ekbom A; Malmborg P; Ludvigsson JF
• Article: RHEUMATOLOGY. 2019;:1367-1377

  Comparative effectiveness of abatacept, rituximab, tocilizumab and TNFi biologics in RA: results from the nationwide Swedish register.

  Frisell T; Dehlin M; Di Giuseppe D; Feltelius N; Turesson C; Askling J; ARTIS Study Group
• Article: SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY. 2019;54(1):55-63

  Changes in inflammatory bowel disease subtype during follow-up and over time in 44,302 patients.

  Everhov ÅH; Sachs MC; Malmborg P; Nordenvall C; Myrelid P; Khalili H; Elmberg M; Ekbom A; Askling J; Jakobsson G; Halfvarson J; Ludvigsson JF; Olén O
• Article: LIVER INTERNATIONAL. 2019;39(1):197-204

  Cardiovascular risk factors in non-alcoholic fatty liver disease.

  Hagström H; Nasr P; Ekstedt M; Hammar U; Stål P; Askling J; Hultcrantz R; Kechagias S
• Article: RMD OPEN. 2019;5(2):e001079

  Treatment retention of infliximab and etanercept originators versus their corresponding biosimilars: Nordic collaborative observational study of 2334 biologics naïve patients with spondyloarthritis.

  Lindström U; Glintborg B; Di Giuseppe D; Nordström D; Aarrestad Provan S; Gudbjornsson B; Askling J; Lund Hetland M; Aaltonen K; Krogh NS; Geirsson AJ; Jacobsson LTH
• Article: RMD OPEN. 2019;5(2):e000978

  Occupational exposure to asbestos and silica and risk of developing rheumatoid arthritis: findings from a Swedish population-based case-control study.

  Ilar A; Klareskog L; Saevarsdottir S; Wiebert P; Askling J; Gustavsson P; Alfredsson L
• Article: RMD OPEN. 2019;5(2):e001055

  Juvenile idiopathic arthritis and risk of cancer before and after the introduction of biological therapies.

  Horne A; Delcoigne B; Palmblad K; Askling J
• Article: JOURNAL OF CROHNS & COLITIS. 2018;12(12):1418-1428

  Sick Leave and Disability Pension in Prevalent Patients With Crohn's Disease.

  Everhov ÅH; Khalili H; Askling J; Myrelid P; Ludvigsson JF; Halfvarson J; Nordenvall C; Söderling J; Olén O; Neovius M
• Article: SCANDINAVIAN JOURNAL OF RHEUMATOLOGY. 2018;47(6):465-474

  Biological treatment in ankylosing spondylitis in the Nordic countries during 2010-2016: a collaboration between five biological registries.

  Glintborg B; Lindström U; Aaltonen K; Kristianslund EK; Gudbjornsson B; Chatzidionysiou K; Askling J; Nordström D; Hetland ML; Di Giuseppe D; Dreyer L; Kristensen LE; Jørgensen TS; Eklund K; Grondal G; Ernestam S; Joensuu J; Törmänen M; Skydsgaard H; Hagfors J; Kvien TK; Lie E; Fagerli K; Geirsson AJ; Jonsson H; Provan SA; Krogh NS; Jacobsson L
• Article: AMERICAN JOURNAL OF GASTROENTEROLOGY. 2018;113(11):1711-1719

  Pancreatic Cancer Following Acute Pancreatitis: A Population-based Matched Cohort Study.

  Sadr-Azodi O; Oskarsson V; Discacciati A; Videhult P; Askling J; Ekbom A
• Article: JAMA NETWORK OPEN. 2018;1(6):e183567

  Risk of Thyroxine-Treated Autoimmune Thyroid Disease Associated With Disease Onset in Patients With Rheumatoid Arthritis.

  Waldenlind K; Saevarsdottir S; Bengtsson C; Askling J
• Article: ARTHRITIS CARE & RESEARCH. 2018;70(10):1563-1567

  Tuberculosis Risk in Ankylosing Spondylitis, Other Spondyloarthritis, and Psoriatic Arthritis in Sweden: A Population-Based Cohort Study.

  de Vries MK; Arkema EV; Jonsson J; Bruchfeld J; Jacobsson LTH; Askling J; ARTIS Study Group
• Letter: ANNALS OF THE RHEUMATIC DISEASES. 2018;77(10):1536-1537

  Transmission of rheumatoid arthritis through blood transfusion: a retrospective cohort study.

  Just SA; Rostgaard K; Titlestad K; Edgren G; Erikstrup C; Ullum H; Pedersen OB; Nielsen KR; Askling J; Lindegaard H; Hjalgrim H
• Article: ANNALS OF INTERNAL MEDICINE. 2018;169(5):291-299

  Tumor Necrosis Factor Inhibitors and Cancer Recurrence in Swedish Patients With Rheumatoid Arthritis: A Nationwide Population-Based Cohort Study.

  Raaschou P; Söderling J; Turesson C; Askling J; ARTIS Study Group
• Article: ARTHRITIS RESEARCH & THERAPY. 2018;20(1):175

  Mediterranean diet and risk of rheumatoid arthritis: a population-based case-control study.

  Johansson K; Askling J; Alfredsson L; Di Giuseppe D; EIRA study group
• Letter: ANNALS OF THE RHEUMATIC DISEASES. 2018;77(8):1236-1238

  Seropositivity combined with smoking is associated with increased prevalence of periodontitis in patients with rheumatoid arthritis.

  Eriksson K; Nise L; Alfredsson L; Catrina AI; Askling J; Lundberg K; Klareskog L; Yucel-Lindberg T
• Article: EUROPEAN RESPIRATORY JOURNAL. 2018;52(2):1800385

  Familial aggregation and heritability of sarcoidosis: a Swedish nested case-control study.

  Rossides M; Grunewald J; Eklund A; Kullberg S; Di Giuseppe D; Askling J; Arkema EV
• Article: SCANDINAVIAN JOURNAL OF RHEUMATOLOGY. 2018;47(4):270-275

  Anti-cyclic citrullinated peptide antibodies, other common autoantibodies, and smoking as risk factors for lymphoma in patients with rheumatoid arthritis.

  Baecklund E; Backlin C; Rönnelid J; Toes R; Huizinga T; Åhlin E; Askling J; Hochberg FH; Klareskog L; Kay J; Smedby KE
• Article: EXPERT OPINION ON BIOLOGICAL THERAPY. 2018;18(5):499-504

  Uptake of rheumatology biosimilars in the absence of forced switching.

  Di Giuseppe D; Frisell T; Ernestam S; Forsblad-D'Elia H; Lindqvist E; Lindström U; Sjöwall C; Askling J; ARTIS group
• Article: ANNALS OF THE RHEUMATIC DISEASES. 2018;77(5):650-657

  Patient characteristics influence the choice of biological drug in RA, and will make non-TNFi biologics appear more harmful than TNFi biologics.

  Frisell T; Baecklund E; Bengtsson K; Di Giuseppe D; Forsblad-d'Elia H; Askling J; ARTIS Study group
• Review: ANNALS OF THE RHEUMATIC DISEASES. 2018;77(4):476-479

  2017 EULAR recommendations for a core data set to support observational research and clinical care in rheumatoid arthritis.

  Radner H; Chatzidionysiou K; Nikiphorou E; Gossec L; Hyrich KL; Zabalan C; van Eijk-Hustings Y; Williamson PR; Balanescu A; Burmester GR; Carmona L; Dougados M; Finckh A; Haugeberg G; Hetland ML; Oliver S; Porter D; Raza K; Ryan P; Santos MJ; van der Helm-van Mil A; van Riel P; von Krause G; Zavada J; Dixon WG; Askling J
• Article: ANNALS OF THE RHEUMATIC DISEASES. 2018;77(4):541-548

  Risk of cardiac rhythm disturbances and aortic regurgitation in different spondyloarthritis subtypes in comparison with general population: a register-based study from Sweden.

  Bengtsson K; Forsblad-d'Elia H; Lie E; Klingberg E; Dehlin M; Exarchou S; Lindström U; Askling J; Jacobsson LTH
• Article: GASTROENTEROLOGY. 2018;154(3):518-528.e15

  Incidence and Treatment of Patients Diagnosed With Inflammatory Bowel Diseases at 60 Years or Older in Sweden.

  Everhov ÅH; Halfvarson J; Myrelid P; Sachs MC; Nordenvall C; Söderling J; Ekbom A; Neovius M; Ludvigsson JF; Askling J; Olén O
• Article: EUROPEAN RESPIRATORY JOURNAL. 2018;51(2):1701815

  Sarcoidosis mortality in Sweden: a population-based cohort study.

  Rossides M; Kullberg S; Askling J; Eklund A; Grunewald J; Arkema EV
• Article: JOURNAL OF CROHNS & COLITIS. 2018;12(2):157-166

  Surgical Treatment in Childhood-onset Inflammatory Bowel Disease-A Nationwide Register-based Study of 4695 Incident Patients in Sweden 2002-2014.

  Nordenvall C; Rosvall O; Bottai M; Everhov ÅH; Malmborg P; Smedby KE; Ekbom A; Askling J; Ludvigsson JF; Myrelid P; Olén O
• Article: ANNALS OF THE RHEUMATIC DISEASES. 2018;77(1):85-91

  Mortality following new-onset Rheumatoid Arthritis: has modern Rheumatology had an impact?

  Holmqvist M; Ljung L; Askling J
• Article: RMD OPEN. 2018;4(2):e000771

  Performance of the Expanded Cardiovascular Risk Prediction Score for Rheumatoid Arthritis in a geographically distant National Register-based cohort: an external validation.

  Ljung L; Ueda P; Liao KP; Greenberg JD; Etzel CJ; Solomon DH; Askling J
• Review: RMD OPEN. 2018;4(1):e000655

  Opportunities and challenges for real-world studies on chronic inflammatory joint diseases through data enrichment and collaboration between national registers: the Nordic example.

  Chatzidionysiou K; Hetland ML; Frisell T; Di Giuseppe D; Hellgren K; Glintborg B; Nordström D; Aaltonen K; Törmänen MR; Klami Kristianslund E; Kvien TK; Provan SA; Björn Guðbjörnsson B; Dreyer L; Kristensen LE; Jørgensen TS; Jacobsson L; Askling J
• Article: RMD OPEN. 2018;4(2):e000762

  Impact of extra-articular spondyloarthritis manifestations and comorbidities on drug retention of a first TNF-inhibitor in ankylosing spondylitis: a population-based nationwide study.

  Lindström U; Olofsson T; Wedrén S; Qirjazo I; Askling J
• Article: ANNALS OF THE RHEUMATIC DISEASES. 2017;76(12):2017-2024

  Long-term outcomes and secondary prevention after acute coronary events in patients with rheumatoid arthritis.

  Mantel Ä; Holmqvist M; Jernberg T; Wållberg-Jonsson S; Askling J
• Article: ANNALS OF THE RHEUMATIC DISEASES. 2017;76(12):2025-2030

  Spectrum of lymphomas across different drug treatment groups in rheumatoid arthritis: a European registries collaborative project.

  Mercer LK; Regierer AC; Mariette X; Dixon WG; Baecklund E; Hellgren K; Dreyer L; Hetland ML; Cordtz R; Hyrich K; Strangfeld A; Zink A; Canhao H; Hernandez MV; Tubach F; Gottenberg J-E; Morel J; Zavada J; Iannone F; Askling J; Listing J
• Article: JAMA INTERNAL MEDICINE. 2017;177(11):1605-1612

  Malignant Neoplasms in Patients With Rheumatoid Arthritis Treated With Tumor Necrosis Factor Inhibitors, Tocilizumab, Abatacept, or Rituximab in Clinical Practice: A Nationwide Cohort Study From Sweden.

  Wadström H; Frisell T; Askling J; Anti-Rheumatic Therapy in Sweden (ARTIS) Study Gro
• Article: ANNALS OF THE RHEUMATIC DISEASES. 2017;76(11):1809-1814

  Juvenile onset arthritis and pregnancy outcome: a population-based cohort study.

  Remaeus K; Johansson K; Askling J; Stephansson O
• Article: ANNALS OF THE RHEUMATIC DISEASES. 2017;76(10):1642-1647

  Acute coronary syndrome in new-onset rheumatoid arthritis: a population-based nationwide cohort study of time trends in risks and excess risks.

  Holmqvist M; Ljung L; Askling J
• Article: BMJ-BRITISH MEDICAL JOURNAL. 2017;358:j3951

  Childhood onset inflammatory bowel disease and risk of cancer: a Swedish nationwide cohort study 1964-2014.

  Olén O; Askling J; Sachs MC; Frumento P; Neovius M; Smedby KE; Ekbom A; Malmborg P; Ludvigsson JF
• Article: ALIMENTARY PHARMACOLOGY & THERAPEUTICS. 2017;46(6):589-598

  Anti-TNF treatment in Crohn's disease and risk of bowel resection-a population based cohort study.

  Eberhardson M; Söderling JK; Neovius M; Cars T; Myrelid P; Ludvigsson JF; Askling J; Ekbom A; Olén O
• Article: ANNALS OF THE RHEUMATIC DISEASES. 2017;76(9):1515-1521

  Tumour necrosis factor inhibitor treatment and occurrence of anterior uveitis in ankylosing spondylitis: results from the Swedish biologics register.

  Lie E; Lindström U; Zverkova-Sandström T; Olsen IC; Forsblad-d'Elia H; Askling J; Kapetanovic MC; Kristensen LE; Jacobsson LTH
• Editorial comment: ARTHRITIS & RHEUMATOLOGY. 2017;69(8):1509-1511

  Editorial: Is Rheumatoid Arthritis a Mortal Disease?

  Askling J; Holmqvist M; Ljung L
• Article: ANNALS OF THE RHEUMATIC DISEASES. 2017;76(7):1245-1252

  Predictors of work disability after start of anti-TNF therapy in a national cohort of Swedish patients with rheumatoid arthritis: does early anti-TNF therapy bring patients back to work?

  Olofsson T; Petersson IF; Eriksson JK; Englund M; Nilsson JA; Geborek P; Jacobsson LTH; Askling J; Neovius M; ARTIS Study Group
• Article: ARTHRITIS RESEARCH & THERAPY. 2017;19(1):102

  Are ankylosing spondylitis, psoriatic arthritis and undifferentiated spondyloarthritis associated with an increased risk of cardiovascular events? A prospective nationwide population-based cohort study.

  Bengtsson K; Forsblad-d'Elia H; Lie E; Klingberg E; Dehlin M; Exarchou S; Lindström U; Askling J; Jacobsson LTH
• Article: AMERICAN JOURNAL OF EPIDEMIOLOGY. 2017;185(8):681-687

  Possible Interaction Between Cigarette Smoking and HLA-DRB1 Variation in the Risk of Follicular Lymphoma.

  Baecklund F; Foo J-N; Askling J; Eloranta S; Glimelius I; Liu J; Hjalgrim H; Rosenquist R; Padyukov L; Smedby KE
• Article: ARTHRITIS & RHEUMATOLOGY. 2017;69(4):700-708

  Rheumatoid Arthritis and Risk of Malignant Lymphoma: Is the Risk Still Increased?

  Hellgren K; Baecklund E; Backlin C; Sundstrom C; Smedby KE; Askling J
• Article: RHEUMATOLOGY. 2017;56(4):613-619

  Cervical neoplasia in systemic lupus erythematosus: a nationwide study.

  Wadström H; Arkema EV; Sjöwall C; Askling J; Simard JF
• Article: JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY. 2017;69(10):1275-1285

  Association Between Rheumatoid Arthritis and Risk of Ischemic and Nonischemic Heart Failure.

  Mantel Ä; Holmqvist M; Andersson DC; Lund LH; Askling J
• Article: ANNALS OF THE RHEUMATIC DISEASES. 2017;76(2):386-391

  Risk of invasive melanoma in patients with rheumatoid arthritis treated with biologics: results from a collaborative project of 11 European biologic registers.

  Mercer LK; Askling J; Raaschou P; Dixon WG; Dreyer L; Hetland ML; Strangfeld A; Zink A; Mariette X; Finckh A; Canhao H; Iannone F; Zavada J; Morel J; Gottenberg J-E; Hyrich KL; Listing J
• Article: ANNALS OF THE RHEUMATIC DISEASES. 2017;76(2):364-370

  Is ankylosing spondylitis a risk factor for cardiovascular disease, and how do these risks compare with those in rheumatoid arthritis?

  Eriksson JK; Jacobsson L; Bengtsson K; Askling J
• Article: BMC GASTROENTEROLOGY. 2017;17(1):23

  Prevalence of paediatric inflammatory bowel disease in Sweden: a nationwide population-based register study.

  Ludvigsson JF; Büsch K; Olén O; Askling J; Smedby KE; Ekbom A; Lindberg E; Neovius M
• Article: RMD OPEN. 2017;3(2):e000498

  Infection rates in patients from five rheumatoid arthritis (RA) registries: contextualising an RA clinical trial programme.

  Yamanaka H; Askling J; Berglind N; Franzen S; Frisell T; Garwood C; Greenberg JD; Ho M; Holmqvist M; Novelli Horne L; Inoue E; Michaud K; Pappas DA; Reed G; Symmons D; Tanaka E; Tran TN; Verstappen SMM; Wesby-van Swaay E; Nyberg F
• Article: ANNALS OF THE RHEUMATIC DISEASES. 2017;76(1):119-125

  How well do ACPA discriminate and predict RA in the general population: a study based on 12 590 population-representative Swedish twins.

  Hensvold AH; Frisell T; Magnusson PKE; Holmdahl R; Askling J; Catrina AI
• Article: ANNALS OF THE RHEUMATIC DISEASES. 2017;76(1):105-111

  Cancer risk in patients with spondyloarthritis treated with TNF inhibitors: a collaborative study from the ARTIS and DANBIO registers.

  Hellgren K; Dreyer L; Arkema EV; Glintborg B; Jacobsson LTH; Kristensen L-E; Feltelius N; Hetland ML; Askling J; ARTIS Study Group, For the DANBIO Study Group
• Article: ARTHRITIS & RHEUMATOLOGY. 2017;69(1):143-147

  Brief Report: Sex Ratio of Offspring Born to Women With Systemic Lupus Erythematosus or Rheumatoid Arthritis.

  Arkema EV; Askling J; Salmon JE; Simard JF
• Article: ARTHRITIS RESEARCH & THERAPY. 2016;18(1):288

  A genetic risk score composed of rheumatoid arthritis risk alleles, HLA-DRB1 haplotypes, and response to TNFi therapy - results from a Swedish cohort study.

  Jiang X; Askling J; Saevarsdottir S; Padyukov L; Alfredsson L; Viatte S; Frisell T
• Article: EUROPEAN RESPIRATORY JOURNAL. 2016;48(6):1690-1699

  Sarcoidosis incidence and prevalence: a nationwide register-based assessment in Sweden.

  Arkema EV; Grunewald J; Kullberg S; Eklund A; Askling J
• Article: ANNALS OF THE RHEUMATIC DISEASES. 2016;75(12):2087-2094

  Response to biological treatment and subsequent risk of coronary events in rheumatoid arthritis.

  Ljung L; Rantapää-Dahlqvist S; Jacobsson LTH; Askling J
• Article: AMERICAN JOURNAL OF GASTROENTEROLOGY. 2016;111(11):1614-1620

  Oral Contraceptive Use and Risk of Ulcerative Colitis Progression: A Nationwide Study.

  Khalili H; Neovius M; Ekbom A; Ludvigsson JF; Askling J; Chan AT; Olen O
• Review: ARTHRITIS RESEARCH & THERAPY. 2016;18(1):251

  Patient global assessment in measuring disease activity in rheumatoid arthritis: a review of the literature.

  Nikiphorou E; Radner H; Chatzidionysiou K; Desthieux C; Zabalan C; van Eijk-Hustings Y; Dixon WG; Hyrich KL; Askling J; Gossec L
• Article: ARTHRITIS RESEARCH & THERAPY. 2016;18(1):240

  Childhood hospitalisation with infections and later development of ankylosing spondylitis: a national case-control study.

  Lindström U; Exarchou S; Lie E; Dehlin M; Forsblad-d'Elia H; Askling J; Jacobsson L
• Article: ANNALS OF THE RHEUMATIC DISEASES. 2016;75(10):1797-1805

  Can rheumatoid arthritis (RA) registries provide contextual safety data for modern RA clinical trials? The case for mortality and cardiovascular disease.

  Michaud K; Berglind N; Franzén S; Frisell T; Garwood C; Greenberg JD; Ho M; Holmqvist M; Horne L; Inoue E; Nyberg F; Pappas DA; Reed G; Symmons D; Tanaka E; Tran TN; Verstappen SMM; Wesby-van Swaay E; Yamanaka H; Askling J
• Article: ANNALS OF THE RHEUMATIC DISEASES. 2016;75(10):1789-1796

  How comparable are rates of malignancies in patients with rheumatoid arthritis across the world? A comparison of cancer rates, and means to optimise their comparability, in five RA registries.

  Askling J; Berglind N; Franzen S; Frisell T; Garwood C; Greenberg JD; Ho M; Holmqvist M; Horne L; Inoue E; Michaud K; Nyberg F; Pappas DA; Reed G; Tanaka E; Tran TN; Verstappen SMM; Yamanaka H; Wesby-van Swaay E; Symmons D
• Article: ANNALS OF THE RHEUMATIC DISEASES. 2016;75(10):1838-1842

  Pregnancy outcomes in patients with ankylosing spondylitis: a nationwide register study.

  Jakobsson GL; Stephansson O; Askling J; Jacobsson LTH
• Article: ANNALS OF THE RHEUMATIC DISEASES. 2016;75(8):1466-1472

  Mortality in ankylosing spondylitis: results from a nationwide population-based study.

  Exarchou S; Lie E; Lindström U; Askling J; Forsblad-d'Elia H; Turesson C; Kristensen LE; Jacobsson LT
• Article: ANNALS OF THE RHEUMATIC DISEASES. 2016;75(7):1272-1278

  Do RA or TNF inhibitors increase the risk of cervical neoplasia or of recurrence of previous neoplasia? A nationwide study from Sweden.

  Wadström H; Frisell T; Sparén P; Askling J; ARTIS study group
• Article: ANNALS OF THE RHEUMATIC DISEASES. 2016;75(6):1120-1125

  Does a family history of RA influence the clinical presentation and treatment response in RA?

  Frisell T; Saevarsdottir S; Askling J
• Review: NATURE REVIEWS RHEUMATOLOGY. 2016;12(6):335-343

  Family history of rheumatoid arthritis: an old concept with new developments.

  Frisell T; Saevarsdottir S; Askling J
• Article: ANNALS OF THE RHEUMATIC DISEASES. 2016;75(5):862-866

  What is the impact of chronic systemic inflammation such as rheumatoid arthritis on mortality following cancer?

  Simard JF; Ekberg S; Johansson ALV; Askling J
• Article: RHEUMATOLOGY. 2016;55(4):729-734

  Does disease activity at start of biologic therapy influence work-loss in RA patients?

  Olofsson T; Johansson K; Eriksson JK; van Vollenhoven R; Miller H; Petersson IF; Askling J; Neovius M
• Article: BMJ-BRITISH MEDICAL JOURNAL. 2016;352:i262

  Rheumatoid arthritis, anti-tumour necrosis factor treatment, and risk of squamous cell and basal cell skin cancer: cohort study based on nationwide prospectively recorded data from Sweden.

  Raaschou P; Simard JF; Asker Hagelberg C; Askling J; ARTIS Study Group
• Article: ARTHRITIS RESEARCH & THERAPY. 2016;18:16

  Perinatal characteristics, older siblings, and risk of ankylosing spondylitis: a case-control study based on national registers.

  Lindström U; Forsblad-d'Elia H; Askling J; Kristensen LE; Lie E; Exarchou S; Jacobsson L
• Article: ANNALS OF THE RHEUMATIC DISEASES. 2016;75(1):183-189

  Familial aggregation of arthritis-related diseases in seropositive and seronegative rheumatoid arthritis: a register-based case-control study in Sweden.

  Frisell T; Hellgren K; Alfredsson L; Raychaudhuri S; Klareskog L; Askling J
• Article: MULTIPLE SCLEROSIS JOURNAL. 2016;22(1):85-93

  Comparative analysis of first-year fingolimod and natalizumab drug discontinuation among Swedish patients with multiple sclerosis.

  Frisell T; Forsberg L; Nordin N; Kiesel C; Alfredsson L; Askling J; Hillert J; Olsson T; Piehl F
• Article: PLOS ONE. 2016;11(5):e0155956

  Prevalence of Periodontitis in Patients with Established Rheumatoid Arthritis: A Swedish Population Based Case-Control Study.

  Eriksson K; Nise L; Kats A; Luttropp E; Catrina AI; Askling J; Jansson L; Alfredsson L; Klareskog L; Lundberg K; Yucel-Lindberg T
• Article: EUROPEAN HEART JOURNAL. 2015;36(48):3413-3422

  Rheumatoid arthritis is associated with a more severe presentation of acute coronary syndrome and worse short-term outcome.

  Mantel Ä; Holmqvist M; Jernberg T; Wållberg-Jonsson S; Askling J
• Article: ARTHRITIS CARE & RESEARCH. 2015;67(12):1637-1645

  Methodological Challenges When Comparing Demographic and Clinical Characteristics of International Observational Registries.

  Verstappen SMM; Askling J; Berglind N; Franzen S; Frisell T; Garwood C; Greenberg JD; Holmqvist M; Horne L; Lampl K; Michaud K; Nyberg F; Pappas DA; Reed G; Symmons DPM; Tanaka E; Tran TN; Yamanaka H; Ho M
• Article: ANNALS OF THE RHEUMATIC DISEASES. 2015;74(12):2137-2143

  TNF inhibitor therapy and risk of breast cancer recurrence in patients with rheumatoid arthritis: a nationwide cohort study.

  Raaschou P; Frisell T; Askling J; ARTIS Study Group
• Article: SCANDINAVIAN JOURNAL OF RHEUMATOLOGY. 2015;44(6):431-437

  Effectiveness and survival-on-drug of certolizumab pegol in rheumatoid arthritis in clinical practice: results from the national Swedish register.

  Chatzidionysiou K; Kristensen L-E; Eriksson J; Askling J; van Vollenhoven R; ARTIS Group
• Article: SCANDINAVIAN JOURNAL OF UROLOGY. 2015;49(6):486-491

  Surgical interventions for nephrolithiasis in ankylosing spondylitis and the general population.

  Jakobsen AK; Jacobsson LTH; Patschan O; Hopfgarten T; Askling J; Kristensen LE
• Article: PHARMACOEPIDEMIOLOGY AND DRUG SAFETY. 2015;24(11):1121-1132

  Using epidemiological registry data to provide background rates as context for adverse events in a rheumatoid arthritis drug development program: a coordinated approach.

  Nyberg F; Askling J; Berglind N; Franzén S; Ho M; Holmqvist M; Horne L; Lampl K; Michaud K; Pappas DA; Reed G; Symmons D; Tanaka E; Tran TN; Verstappen SMM; Wesby-van Swaay E; Yamanaka H; Greenberg JD
• Article: ARTHRITIS & RHEUMATOLOGY. 2015;67(11):2845-2854

  Risk factors for the rapid increase in risk of acute coronary events in patients with new-onset rheumatoid arthritis: a nested case-control study.

  Mantel Ä; Holmqvist M; Nyberg F; Tornling G; Frisell T; Alfredsson L; Askling J
• Article: SCANDINAVIAN JOURNAL OF RHEUMATOLOGY. 2015;44(5):369-376

  Validity of ankylosing spondylitis and undifferentiated spondyloarthritis diagnoses in the Swedish National Patient Register.

  Lindström U; Exarchou S; Sigurdardottir V; Sundström B; Askling J; Eriksson JK; Forsblad-d'Elia H; Turesson C; Kristensen LE; Jacobsson L
• Article: ARTHRITIS CARE & RESEARCH. 2015;67(9):1219-1229

  Consistency and Utility of Data Items Across European Rheumatoid Arthritis Clinical Cohorts and Registers.

  Radner H; Dixon W; Hyrich K; Askling J
• Article: ARTHRITIS CARE & RESEARCH. 2015;67(8):1137-1149

  Safety of Etoricoxib, Celecoxib, and Nonselective Nonsteroidal Antiinflammatory Drugs in Ankylosing Spondylitis and Other Spondyloarthritis Patients: A Swedish National Population-Based Cohort Study.

  Kristensen LE; Jakobsen AK; Askling J; Nilsson F; Jacobsson LTH
• Article: ANNALS OF THE RHEUMATIC DISEASES. 2015;74(8):1522-1529

  Improved performance of epidemiologic and genetic risk models for rheumatoid arthritis serologic phenotypes using family history.

  Sparks JA; Chen C-Y; Jiang X; Askling J; Hiraki LT; Malspeis S; Klareskog L; Alfredsson L; Costenbader KH; Karlson EW
• Article: RHEUMATOLOGY. 2015;54(8):1472-1477

  Does disease activity at the start of biologic therapy influence health care costs in patients with RA?

  Johansson K; Eriksson JK; van Vollenhoven R; Miller H; Askling J; Neovius M; ARTIS Study Group
• Article: RHEUMATOLOGY. 2015;54(6):1074-1079

  The EULAR Study Group for Registers and Observational Drug Studies: comparability of the patient case mix in the European biologic disease modifying anti-rheumatic drug registers.

  Kearsley-Fleet L; Závada J; Hetland ML; Nordström DC; Aaltonen KJ; Listing J; Zink A; Gati T; Rojkovich B; Iannone F; Gremese E; van Riel PLCM; van de Laar MAFJ; Lie E; Kvien TK; Canhão H; Fonseca JE; Rotar Ž; Loza E; Carmona L; Askling J; Johansson K; Finckh A; Dixon WG; Hyrich KL
• Article: ANNALS OF THE RHEUMATIC DISEASES. 2015;74(6):970-978

  The effect of comedication with conventional synthetic disease modifying antirheumatic drugs on TNF inhibitor drug survival in patients with ankylosing spondylitis and undifferentiated spondyloarthritis: results from a nationwide prospective study.

  Lie E; Kristensen LE; Forsblad-d'Elia H; Zverkova-Sandström T; Askling J; Jacobsson LT; ARTIS Study Group
• Article: ANNALS OF THE RHEUMATIC DISEASES. 2015;74(6):1212-1217

  Are patients with rheumatoid arthritis still at an increased risk of tuberculosis and what is the role of biological treatments?

  Arkema EV; Jonsson J; Baecklund E; Bruchfeld J; Feltelius N; Askling J; ARTIS Study Group
• Article: ARTHRITIS RESEARCH & THERAPY. 2015;17(1):118

  The prevalence of clinically diagnosed ankylosing spondylitis and its clinical manifestations: a nationwide register study.

  Exarchou S; Lindström U; Askling J; Eriksson JK; Forsblad-d'Elia H; Neovius M; Turesson C; Kristensen LE; Jacobsson LTH
• Article: ANNALS OF THE RHEUMATIC DISEASES. 2015;74(5):890-896

  Effectiveness of TNF inhibitor switch in RA: results from the national Swedish register.

  Chatzidionysiou K; Askling J; Eriksson J; Kristensen LE; van Vollenhoven R; ARTIS group
• Article: JOURNAL OF INTERNAL MEDICINE. 2015;277(5):594-604

  The autoimmune spectrum of myasthenia gravis: a Swedish population-based study.

  Fang F; Sveinsson O; Thormar G; Granqvist M; Askling J; Lundberg IE; Ye W; Hammarström L; Pirskanen R; Piehl F
• Article: ANNALS OF THE RHEUMATIC DISEASES. 2015;74(4):648-654

  Costs for hospital care, drugs and lost work days in incident and prevalent rheumatoid arthritis: how large, and how are they distributed?

  Eriksson JK; Johansson K; Askling J; Neovius M
• Article: JOURNAL OF RHEUMATOLOGY. 2015;42(4):690-694

  Leukemia and myelodysplastic syndrome in granulomatosis with polyangiitis: subtypes, clinical characteristics, and outcome.

  Knight A; Hjorton K; Sundström C; Höglund M; Backlin C; Smedby KE; Askling J; Baecklund E
• Article: ARTHRITIS RESEARCH & THERAPY. 2015;17(1):40

  Physical activity and risk of rheumatoid arthritis in women: a population-based prospective study.

  Di Giuseppe D; Bottai M; Askling J; Wolk A
• Article: ANNALS OF THE RHEUMATIC DISEASES. 2015;74(2):375-380

  Environmental and genetic factors in the development of anticitrullinated protein antibodies (ACPAs) and ACPA-positive rheumatoid arthritis: an epidemiological investigation in twins.

  Hensvold AH; Magnusson PKE; Joshua V; Hansson M; Israelsson L; Ferreira R; Jakobsson P-J; Holmdahl R; Hammarström L; Malmström V; Askling J; Klareskog L; Catrina AI
• Article: ANNALS OF THE RHEUMATIC DISEASES. 2015;74(2):354-360

  Drug survival on TNF inhibitors in patients with rheumatoid arthritis comparison of adalimumab, etanercept and infliximab.

  Neovius M; Arkema EV; Olsson H; Eriksson JK; Kristensen LE; Simard JF; Askling J; ARTIS Study Group
• Article: ARTHRITIS & RHEUMATOLOGY. 2015;67(2):352-362

  To what extent is the familial risk of rheumatoid arthritis explained by established rheumatoid arthritis risk factors?

  Jiang X; Frisell T; Askling J; Karlson EW; Klareskog L; Alfredsson L; Källberg H
• Article: SCANDINAVIAN JOURNAL OF RHEUMATOLOGY. 2015;44(1):22-28

  How good is the coverage and how accurate are exposure data in the Swedish Biologics Register (ARTIS)?

  Wadström H; Eriksson JK; Neovius M; Askling J; ARTIS Study Group
• Article: BMC MUSCULOSKELETAL DISORDERS. 2014;15:432

  Validation of the rheumatoid arthritis diagnosis in the Swedish National Patient Register: a cohort study from Stockholm County.

  Waldenlind K; Eriksson JK; Grewin B; Askling J
• Letter: ANNALS OF THE RHEUMATIC DISEASES. 2014;73(11):2061-2062

  No association between rheumatoid arthritis, amyotrophic lateral sclerosis, and tumour necrosis factor inhibitor treatment.

  Arkema EV; Feltelius N; Olsson T; Askling J; ARTIS study group
• Article: SCHIZOPHRENIA BULLETIN. 2014;40(6):1552-1559

  The association between schizophrenia and rheumatoid arthritis: a nationwide population-based Swedish study on intraindividual and familial risks.

  Sellgren C; Frisell T; Lichtenstein P; Landèn M; Askling J
• Article: ANNALS OF THE RHEUMATIC DISEASES. 2014;73(11):1949-1953

  Long-term intake of dietary long-chain n-3 polyunsaturated fatty acids and risk of rheumatoid arthritis: a prospective cohort study of women.

  Di Giuseppe D; Wallin A; Bottai M; Askling J; Wolk A
• Article: CLINICAL AND EXPERIMENTAL RHEUMATOLOGY. 2014;32(5 Suppl 85):S-147-9

  The Swedish Rheumatology Quality Register: optimisation of rheumatic disease assessments using register-enriched data.

  Eriksson JK; Askling J; Arkema EV
• Article: ARTHRITIS RESEARCH & THERAPY. 2014;16(3):R127

  The risk of acute coronary syndrome in rheumatoid arthritis in relation to tumour necrosis factor inhibitors and the risk in the general population: a national cohort study.

  Ljung L; Askling J; Rantapää-Dahlqvist S; Jacobsson L; ARTIS Study Group
• Article: BMC CANCER. 2014;14:391

  Aspirin intake and breast cancer survival - a nation-wide study using prospectively recorded data in Sweden.

  Holmes MD; Olsson H; Pawitan Y; Holm J; Lundholm C; Andersson TM-L; Adami H-O; Askling J; Smedby KE
• Letter: ANNALS OF THE RHEUMATIC DISEASES. 2014;73(6):e32

  Response to: 'Drug survival on TNF inhibitors: 2003-2004 data from Italian National Register (GISEA Register)' by Iannone et al.

  Neovius M; Askling J
• Article: ANNALS OF THE RHEUMATIC DISEASES. 2014;73(5):845-853

  Predictors of work disability during the first 3 years after diagnosis in a national rheumatoid arthritis inception cohort.

  Olofsson T; Petersson IF; Eriksson JK; Englund M; Simard JF; Nilsson J-Å; Geborek P; Jacobsson LTH; Askling J; Neovius M
• Article: ARTHRITIS & RHEUMATOLOGY. 2014;66(5):1282-1290

  Ankylosing spondylitis, psoriatic arthritis, and risk of malignant lymphoma: a cohort study based on nationwide prospectively recorded data from Sweden.

  Hellgren K; Smedby KE; Backlin C; Sundstrom C; Feltelius N; Eriksson JK; Baecklund E; Askling J
• Letter: ANNALS OF THE RHEUMATIC DISEASES. 2014;73(3):628

  Launch of a checklist for reporting longitudinal observational drug studies in rheumatology: a EULAR extension of STROBE guidelines based on experience from biologics registries.

  Zavada J; Dixon WG; Askling J; EULAR Study group on Longitudinal Observational Re
• Article: JOURNAL OF INTERNAL MEDICINE. 2014;275(2):172-190

  Risks of neurological and immune-related diseases, including narcolepsy, after vaccination with Pandemrix: a population- and registry-based cohort study with over 2 years of follow-up.

  Persson I; Granath F; Askling J; Ludvigsson JF; Olsson T; Feltelius N
• Review: SEMINARS IN CANCER BIOLOGY. 2014;24:61-70

  Lymphoma development in patients with autoimmune and inflammatory disorders--what are the driving forces?

  Baecklund E; Smedby KE; Sutton L-A; Askling J; Rosenquist R
• Article: ALIMENTARY PHARMACOLOGY & THERAPEUTICS. 2014;39(1):57-68

  Nationwide prevalence of inflammatory bowel disease in Sweden: a population-based register study.

  Büsch K; Ludvigsson JF; Ekström-Smedby K; Ekbom A; Askling J; Neovius M
• Article: PLOS ONE. 2014;9(11):e113602

  Is nephrolithiasis an unrecognized extra-articular manifestation in ankylosing spondylitis? A prospective population-based Swedish national cohort study with matched general population comparator subjects.

  Jakobsen AK; Jacobsson LTH; Patschan O; Askling J; Kristensen LE
• Article: ARTHRITIS & RHEUMATOLOGY. 2013;65(11):2773-2782

  Familial risks and heritability of rheumatoid arthritis: role of rheumatoid factor/anti-citrullinated protein antibody status, number and type of affected relatives, sex, and age.

  Frisell T; Holmqvist M; Källberg H; Klareskog L; Alfredsson L; Askling J
• Article: ANNALS OF THE RHEUMATIC DISEASES. 2013;72(10):1675-1679

  Long-term work disability in patients with psoriatic arthritis treated with anti-tumour necrosis factor: a population-based regional Swedish cohort study.

  Kristensen LE; Englund M; Neovius M; Askling J; Jacobsson LTH; Petersson IF
• Letter: ARTHRITIS & RHEUMATOLOGY. 2013;65(6):1671-1672

  Reply: To PMID 22886739.

  Simard JF; Neovius M; Askling J
• Article: ARTHRITIS CARE & RESEARCH. 2013;65(6):870-878

  Incidence of rheumatoid arthritis in Sweden: a nationwide population-based assessment of incidence, its determinants, and treatment penetration.

  Eriksson JK; Neovius M; Ernestam S; Lindblad S; Simard JF; Askling J
• Article: ARTHRITIS CARE & RESEARCH. 2013;65(5):678-685

  Increased risk of arthropathies and joint replacement surgery in patients with genetic hemochromatosis: a study of 3,531 patients and their 11,794 first-degree relatives.

  Elmberg M; Hultcrantz R; Simard JF; Carlsson Å; Askling J
• Article: ARTHRITIS RESEARCH & THERAPY. 2013;15(2):R56

  Cigarette smoking and smoking cessation in relation to risk of rheumatoid arthritis in women.

  Di Giuseppe D; Orsini N; Alfredsson L; Askling J; Wolk A
• Article: BMJ-BRITISH MEDICAL JOURNAL. 2013;346:f1939

  Rheumatoid arthritis, anti-tumour necrosis factor therapy, and risk of malignant melanoma: nationwide population based prospective cohort study from Sweden.

  Raaschou P; Simard JF; Holmqvist M; Askling J; ARTIS Study Group
• Article: ANNALS OF THE RHEUMATIC DISEASES. 2013;72(4):541-546

  Occurrence and relative risk of stroke in incident and prevalent contemporary rheumatoid arthritis.

  Holmqvist M; Gränsmark E; Mantel A; Alfredsson L; Jacobsson LTH; Wallberg-Jonsson S; Askling J
• Article: PLOS GENETICS. 2013;9(3):e1003394

  Genome-wide association study and gene expression analysis identifies CD84 as a predictor of response to etanercept therapy in rheumatoid arthritis.

  Cui J; Stahl EA; Saevarsdottir S; Miceli C; Diogo D; Trynka G; Raj T; Mirkov MU; Canhao H; Ikari K; Terao C; Okada Y; Wedrén S; Askling J; Yamanaka H; Momohara S; Taniguchi A; Ohmura K; Matsuda F; Mimori T; Gupta N; Kuchroo M; Morgan AW; Isaacs JD; Wilson AG; Hyrich KL; Herenius M; Doorenspleet ME; Tak P-P; Crusius JBA; van der Horst-Bruinsma IE; Wolbink GJ; van Riel PLCM; van de Laar M; Guchelaar H-J; Shadick NA; Allaart CF; Huizinga TWJ; Toes REM; Kimberly RP; Bridges SL; Criswell LA; Moreland LW; Fonseca JE; de Vries N; Stranger BE; De Jager PL; Raychaudhuri S; Weinblatt ME; Gregersen PK; Mariette X; Barton A; Padyukov L; Coenen MJH; Karlson EW; Plenge RM
• Article: LAKARTIDNINGEN. 2013;110(3):82-84

  [Observational cohort studies. Overview and some examples from the field of drug safety].

  Holmqvist M; Raaschou P; Neovius M; Askling J
• Article: ANNALS OF THE RHEUMATIC DISEASES. 2012;71(11):1865-1867

  Incidence of progressive multifocal leukoencephalopathy in patients with rheumatoid arthritis: a national population-based study.

  Arkema EV; van Vollenhoven RF; Askling J; ARTIS Study Group
• Article: ARTHRITIS & RHEUMATOLOGY. 2012;64(11):3502-3510

  Mortality rates in patients with rheumatoid arthritis treated with tumor necrosis factor inhibitors: drug-specific comparisons in the Swedish Biologics Register.

  Simard JF; Neovius M; Askling J; ARTIS Study Group
• Article: JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION. 2012;308(13):1350-1356

  Risk of venous thromboembolism in patients with rheumatoid arthritis and association with disease duration and hospitalization.

  Holmqvist ME; Neovius M; Eriksson J; Mantel Ä; Wållberg-Jonsson S; Jacobsson LTH; Askling J
• Article: JOURNAL OF RHEUMATOLOGY. 2012;39(8):1583-1602

  Canadian Rheumatology Association recommendations for the pharmacological management of rheumatoid arthritis with traditional and biologic disease-modifying antirheumatic drugs: part II safety.

  Bombardier C; Hazlewood GS; Akhavan P; Schieir O; Dooley A; Haraoui B; Khraishi M; Leclercq SA; Légaré J; Mosher DP; Pencharz J; Pope JE; Thomson J; Thorne C; Zummer M; Gardam MA; Askling J; Bykerk V; Canadian Rheumatology Association
• Article: BMJ-BRITISH MEDICAL JOURNAL. 2012;345:e4230

  Long term alcohol intake and risk of rheumatoid arthritis in women: a population based cohort study.

  Di Giuseppe D; Alfredsson L; Bottai M; Askling J; Wolk A
• Article: JOURNAL OF INTERNAL MEDICINE. 2012;272(1):45-54

  Risk of ischaemic heart disease and cardiomyopathy in patients with haemochromatosis and in their first-degree relatives: a nationwide, population-based study.

  Elmberg M; Hultcrantz R; Simard JF; Stål P; Pehrsson K; Askling J
• Article: ARTHRITIS & RHEUMATOLOGY. 2012;64(1):42-52

  Treatment with tumor necrosis factor inhibitors and the risk of acute coronary syndromes in early rheumatoid arthritis.

  Ljung L; Simard JF; Jacobsson L; Rantapää-Dahlqvist S; Askling J; Anti-Rheumatic Therapy in Sweden (ARTIS) Study Gro
• Article: DIGESTIVE AND LIVER DISEASE. 2011;43(11):862-868

  Coeliac disease characteristics, compliance to a gluten free diet and risk of lymphoma by subtype.

  Olén O; Askling J; Ludvigsson JF; Hildebrand H; Ekbom A; Smedby KE
• Letter: CIRCULATION. 2011;124(16):E423

  Response to Letter Regarding Article, "Nationwide Cohort Study of Risk of Ischemic Heart Disease in Patients With Celiac Disease"

  Ludvigsson JF; James S; Askling J; Ingelsson E
• Article: ANNALS OF THE RHEUMATIC DISEASES. 2011;70(8):1407-1414

  Sick leave and disability pension before and after initiation of antirheumatic therapies in clinical practice.

  Neovius M; Simard JF; Klareskog L; Askling J; ARTIS Study Group
• Article: ARTHRITIS & RHEUMATOLOGY. 2011;63(7):1812-1822

  Does cancer that occurs during or after anti-tumor necrosis factor therapy have a worse prognosis? A national assessment of overall and site-specific cancer survival in rheumatoid arthritis patients treated with biologic agents.

  Raaschou P; Simard JF; Neovius M; Askling J; Anti-Rheumatic Therapy in Sweden Study Group
• Article: ANNALS OF THE RHEUMATIC DISEASES. 2011;70(6):1010-1015

  How large are the productivity losses in contemporary patients with RA, and how soon in relation to diagnosis do they develop?

  Neovius M; Simard JF; Askling J; ARTIS Study Group
• Letter: LEUKEMIA & LYMPHOMA. 2011;52(6):1146-1149

  LMO2 protein expression predicts survival in patients with rheumatoid arthritis and diffuse large B-cell lymphoma.

  Baecklund E; Backlin C; Mansouri M; Klareskog L; Askling J; Iliadou AN; Enblad G; Lossos IS; Natkunam Y; Rosenquist R
• Article: INFLAMMATORY BOWEL DISEASES. 2011;17(5):1101-1107

  Colitis-associated DNA aneuploidy and dysplasia in Crohn's disease and risk of colorectal cancer.

  Söderlund S; Tribukait B; Öst Å; Broström O; Karlén P; Löfberg R; Askling J; Sjöqvist U
• Editorial comment: ANNALS OF THE RHEUMATIC DISEASES. 2011;70(4):561-562

  Influence of biological agents on cardiovascular disease in rheumatoid arthritis.

  Askling J; Dixon W
• Article: ANNALS OF THE RHEUMATIC DISEASES. 2011;70(4):624-629

  Nationwide prevalence of rheumatoid arthritis and penetration of disease-modifying drugs in Sweden.

  Neovius M; Simard JF; Askling J; ARTIS study group
• Article: JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE. 2011;103(5):436-444

  Risk of lymphoproliferative malignancy in relation to small intestinal histopathology among patients with celiac disease.

  Elfström P; Granath F; Ekström Smedby K; Montgomery SM; Askling J; Ekbom A; Ludvigsson JF
• Article: ANNALS OF THE RHEUMATIC DISEASES. 2011;70(3):516-519

  Generalisability of clinical registers used for drug safety and comparative effectiveness research: coverage of the Swedish Biologics Register.

  Neovius M; Simard J; Sundström A; Jacobsson L; Geborek P; Saxne T; Feltelius N; Klareskog L; Askling J; ARTIS Study Group
• Article: CIRCULATION. 2011;123(5):483-490

  Nationwide cohort study of risk of ischemic heart disease in patients with celiac disease.

  Ludvigsson JF; James S; Askling J; Stenestrand U; Ingelsson E
• Article: PHARMACOEPIDEMIOLOGY AND DRUG SAFETY. 2011;20(2):119-130

  Cancer risk with tumor necrosis factor alpha (TNF) inhibitors: meta-analysis of randomized controlled trials of adalimumab, etanercept, and infliximab using patient level data.

  Askling J; Fahrbach K; Nordstrom B; Ross S; Schmid CH; Symmons D
• Article: RHEUMATOLOGY. 2011;50(1):204-213

  Ten years with biologics: to whom do data on effectiveness and safety apply?

  Simard JF; Arkema EV; Sundström A; Geborek P; Saxne T; Baecklund E; Coster L; Dackhammar C; Jacobsson L; Feltelius N; Lindblad S; Rantapää-Dahlqvist S; Klareskog L; van Vollenhoven RF; Neovius M; Askling J
• Article: SCANDINAVIAN JOURNAL OF RHEUMATOLOGY. 2011;40(1):8-15

  Small-area variations in sales of TNF inhibitors in Sweden between 2000 and 2009.

  Neovius M; Sundström A; Simard J; Wettermark B; Cars T; Feltelius N; Askling J; Klareskog L; ARTIS Study Group
• Article: ARTHRITIS & RHEUMATOLOGY. 2011;63(1):26-36

  Patients with early rheumatoid arthritis who smoke are less likely to respond to treatment with methotrexate and tumor necrosis factor inhibitors: observations from the Epidemiological Investigation of Rheumatoid Arthritis and the Swedish Rheumatology Register cohorts.

  Saevarsdottir S; Wedrén S; Seddighzadeh M; Bengtsson C; Wesley A; Lindblad S; Askling J; Alfredsson L; Klareskog L
• Article: RHEUMATOLOGY. 2011;50(1):146-151

  Detection and evaluation of a drug safety signal concerning pancreatic cancer: lessons from a joint approach of three European biologics registers.

  Strangfeld A; Hyrich K; Askling J; Arkema E; Davies R; Listing J; Neovius M; Simard J; Symmons D; Watson K; Zink A
• Article: ARTHRITIS & RHEUMATOLOGY. 2010;62(12):3776-3782

  Juvenile idiopathic arthritis and risk of cancer: a nationwide cohort study.

  Simard JF; Neovius M; Hagelberg S; Askling J
• Article: JOURNAL OF INTERNAL MEDICINE. 2010;268(6):578-585

  Rapid increase in myocardial infarction risk following diagnosis of rheumatoid arthritis amongst patients diagnosed between 1995 and 2006.

  Holmqvist ME; Wedrén S; Jacobsson LTH; Klareskog L; Nyberg F; Rantapää-Dahlqvist S; Alfredsson L; Askling J
• Article: JOURNAL OF RHEUMATOLOGY. 2010;37(12):2553-2558

  Increased risk of autoimmune disease in families with Wegener's granulomatosis.

  Knight A; Sandin S; Askling J
• Review: ZEITSCHRIFT FUR RHEUMATOLOGIE. 2010;69(9):774-779

  The risk of malignancies in RA patients treated with biologics.

  Askling J
• Article: JOURNAL OF INTERNAL MEDICINE. 2010;268(4):329-337

  Rheumatoid arthritis and birth outcomes: a Danish and Swedish nationwide prevalence study.

  Nørgaard M; Larsson H; Pedersen L; Granath F; Askling J; Kieler H; Ekbom A; Sørensen HT; Stephansson O
• Article: ANNALS OF THE RHEUMATIC DISEASES. 2010;69(9):1596-1602

  EULAR points to consider when establishing, analysing and reporting safety data of biologics registers in rheumatology.

  Dixon WG; Carmona L; Finckh A; Hetland ML; Kvien TK; Landewe R; Listing J; Nicola PJ; Tarp U; Zink A; Askling J
• Review: SEMINARS IN ARTHRITIS AND RHEUMATISM. 2010;40(1):2-14.e1

  A comparison of patient characteristics and outcomes in selected European and U.S. rheumatoid arthritis registries.

  Curtis JR; Jain A; Askling J; Bridges SL; Carmona L; Dixon W; Finckh A; Hyrich K; Greenberg JD; Kremer J; Listing J; Michaud K; Mikuls T; Shadick N; Solomon DH; Weinblatt ME; Wolfe F; Zink A
• Letter: ARTHRITIS & RHEUMATOLOGY. 2010;62(8):2561

  Ischemic heart disease and rheumatoid arthritis: comment on the article by Holmqvist et al Reply

  Holmqvist M; Askling J
• Article: ARTHRITIS & RHEUMATOLOGY. 2010;62(7):1849-1861

  Rheumatoid arthritis risk allele PTPRC is also associated with response to anti-tumor necrosis factor alpha therapy.

  Cui J; Saevarsdottir S; Thomson B; Padyukov L; van der Helm-van Mil AHM; Nititham J; Hughes LB; de Vries N; Raychaudhuri S; Alfredsson L; Askling J; Wedrén S; Ding B; Guiducci C; Wolbink GJ; Crusius JBA; van der Horst-Bruinsma IE; Herenius M; Weinblatt ME; Shadick NA; Worthington J; Batliwalla F; Kern M; Morgan AW; Wilson AG; Isaacs JD; Hyrich K; Seldin MF; Moreland LW; Behrens TW; Allaart CF; Criswell LA; Huizinga TWJ; Tak PP; Bridges SL; Toes REM; Barton A; Klareskog L; Gregersen PK; Karlson EW; Plenge RM
• Article: JOURNAL OF CYSTIC FIBROSIS. 2010;9(4):288-291

  Cystic fibrosis gene mutations and gastrointestinal diseases.

  Bahmanyar S; Ekbom A; Askling J; Johannesson M; Montgomery SM
• Article: AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE. 2010;181(11):1217-1222

  Smoking, use of moist snuff, and risk of chronic inflammatory diseases.

  Carlens C; Hergens M-P; Grunewald J; Ekbom A; Eklund A; Höglund CO; Askling J
• Article: ARTHRITIS & RHEUMATOLOGY. 2010;62(5):1252-1258

  Do rheumatoid arthritis and lymphoma share risk factors?: a comparison of lymphoma and cancer risks before and after diagnosis of rheumatoid arthritis.

  Hellgren K; Smedby KE; Feltelius N; Baecklund E; Askling J
• Article: GASTROENTEROLOGY. 2010;138(5):1697-1703

  Inflammatory bowel disease confers a lower risk of colorectal cancer to females than to males.

  Söderlund S; Granath F; Broström O; Karlén P; Löfberg R; Ekbom A; Askling J
• Article: ANNALS OF THE RHEUMATIC DISEASES. 2010;69(4):654-659

  Rheumatoid arthritis, treatment with corticosteroids and risk of malignant lymphomas: results from a case-control study.

  Hellgren K; Iliadou A; Rosenquist R; Feltelius N; Backlin C; Enblad G; Askling J; Baecklund E
• Article: ANNALS OF THE RHEUMATIC DISEASES. 2010;69(4):737-740

  Occupational risk factors for Wegener's granulomatosis: a case-control study.

  Knight A; Sandin S; Askling J
• Article: HEPATOLOGY. 2010;51(2):595-602

  Decreased survival of subjects with elevated liver function tests during a 28-year follow-up.

  Söderberg C; Stål P; Askling J; Glaumann H; Lindberg G; Marmur J; Hultcrantz R
• Article: ARTHRITIS RESEARCH & THERAPY. 2010;12(2):R67

  Infections requiring hospitalization in the abatacept clinical development program: an epidemiological assessment.

  Simon TA; Askling J; Lacaille D; Franklin J; Wolfe F; Covucci A; Suissa S; Hochberg MC; Abatacept Epidemiology Study Group
• Article: INTERNATIONAL JOURNAL OF CANCER. 2009;125(12):2953-2956

  Cancer risk among patients with cystic fibrosis and their first-degree relatives.

  Johannesson M; Askling J; Montgomery SM; Ekbom A; Bahmanyar S
• Article: ANNALS OF THE RHEUMATIC DISEASES. 2009;68(12):1819-1826

  Malignancies in the rheumatoid arthritis abatacept clinical development programme: an epidemiological assessment.

  Simon TA; Smitten AL; Franklin J; Askling J; Lacaille D; Wolfe F; Hochberg MC; Qi K; Suissa S
• Article: ARTHRITIS & RHEUMATOLOGY. 2009;60(11):3180-3189

  Cancer risk in patients with rheumatoid arthritis treated with anti-tumor necrosis factor alpha therapies: does the risk change with the time since start of treatment?

  Askling J; van Vollenhoven RF; Granath F; Raaschou P; Fored CM; Baecklund E; Dackhammar C; Feltelius N; Cöster L; Geborek P; Jacobsson LT; Lindblad S; Rantapää-Dahlqvist S; Saxne T; Klareskog L
• Letter: GASTROENTEROLOGY. 2009;137(5):1858

  Is Ulcerative Colitis Proctitis Associated With an Increased Risk of Colorectal Cancer? Reply

  Soderlund S; Brandt L; Lapidus A; Karlen P; Brostrom O; Lofberg R; Ekbom A; Askling J
• Article: ARTHRITIS & RHEUMATOLOGY. 2009;60(10):2861-2869

  No increased occurrence of ischemic heart disease prior to the onset of rheumatoid arthritis: results from two Swedish population-based rheumatoid arthritis cohorts.

  Holmqvist ME; Wedrén S; Jacobsson LTH; Klareskog L; Nyberg F; Rantapää-Dahlqvist S; Alfredsson L; Askling J
• Article: GASTROENTEROLOGY. 2009;137(4):1301-1309

  Increased mortality risk in patients with phenotypic hereditary hemochromatosis but not in their first-degree relatives.

  Elmberg M; Hultcrantz R; Ebrahim F; Olsson S; Lindgren S; Lööf L; Stål P; Wallerstedt S; Almer S; Sandberg-Gertzén H; Ekbom A; Askling J
• Review: ANNALS OF THE RHEUMATIC DISEASES. 2009;68(8):1240-1246

  European biologicals registers: methodology, selected results and perspectives.

  Zink A; Askling J; Dixon WG; Klareskog L; Silman AJ; Symmons DPM
• Article: ANNALS OF THE RHEUMATIC DISEASES. 2009;68(7):1159-1164

  Perinatal characteristics, early life infections and later risk of rheumatoid arthritis and juvenile idiopathic arthritis.

  Carlens C; Jacobsson L; Brandt L; Cnattingius S; Stephansson O; Askling J
• Article: GASTROENTEROLOGY. 2009;136(5):1561-1567

  Decreasing time-trends of colorectal cancer in a large cohort of patients with inflammatory bowel disease.

  Söderlund S; Brandt L; Lapidus A; Karlén P; Broström O; Löfberg R; Ekbom A; Askling J
• Article: ANNALS OF THE RHEUMATIC DISEASES. 2009;68(5):648-653

  Anti-tumour necrosis factor therapy in rheumatoid arthritis and risk of malignant lymphomas: relative risks and time trends in the Swedish Biologics Register.

  Askling J; Baecklund E; Granath F; Geborek P; Fored M; Backlin C; Bertilsson L; Cöster L; Jacobsson LT; Lindblad S; Lysholm J; Rantapää-Dahlqvist S; Saxne T; van Vollenhoven R; Klareskog L; Feltelius N
• Article: MULTIPLE SCLEROSIS JOURNAL. 2009;15(4):431-436

  Effects of infectious mononucleosis and HLA-DRB1*15 in multiple sclerosis.

  Nielsen TR; Rostgaard K; Askling J; Steffensen R; Oturai A; Jersild C; Koch-Henriksen N; Sørensen PS; Hjalgrim H
• Article: ARTHRITIS & RHEUMATOLOGY. 2009;60(3):653-660

  Specific association of type 1 diabetes mellitus with anti-cyclic citrullinated peptide-positive rheumatoid arthritis.

  Liao KP; Gunnarsson M; Källberg H; Ding B; Plenge RM; Padyukov L; Karlson EW; Klareskog L; Askling J; Alfredsson L
• Review: JOURNAL OF INTERNAL MEDICINE. 2008;264(6):514-527

  Autoimmune and inflammatory disorders and risk of malignant lymphomas--an update.

  Smedby KE; Askling J; Mariette X; Baecklund E
• Article: SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY. 2008;43(8):961-966

  Early-life exposures associated with antibiotic use and risk of subsequent Crohn's disease.

  Hildebrand H; Malmborg P; Askling J; Ekbom A; Montgomery SM
• Article: CLINICAL GASTROENTEROLOGY AND HEPATOLOGY. 2008;6(8):939-943

  Increased risk of primary sclerosing cholangitis and ulcerative colitis in first-degree relatives of patients with primary sclerosing cholangitis.

  Bergquist A; Montgomery SM; Bahmanyar S; Olsson R; Danielsson A; Lindgren S; Prytz H; Hultcrantz R; Lööf LARS; Sandberg-Gertzén H; Almer S; Askling J; Ehlin A; Ekbom A
• Review: CURRENT OPINION IN RHEUMATOLOGY. 2008;20(3):334-339

  Malignancy and biologic therapy in rheumatoid arthritis.

  Askling J; Bongartz T
• Article: CLINICAL AND EXPERIMENTAL RHEUMATOLOGY. 2008;26(3 Suppl 49):S53-S56

  What is the significance in routine care of c-ANCA/PR3-ANCA in the absence of systemic vasculitis? A case series.

  Knight A; Ekbom A; Brandt L; Askling J
• Article: BRITISH JOURNAL OF HAEMATOLOGY. 2008;141(1):69-72

  Expression of the human germinal-centre-associated lymphoma protein in diffuse large B-cell lymphomas in patients with rheumatoid arthritis.

  Baecklund E; Natkunam Y; Backlin C; Iliadou A; Askling J; Ekbom A; Feltelius N; Klareskog L; Enblad G; Lossos IS; Levy R; Sundström C; Rosenquist R
• Review: CURRENT OPINION IN RHEUMATOLOGY. 2008;20(2):138-144

  The safety of anti-tumour necrosis factor therapy in rheumatoid arthritis.

  Askling J; Dixon W
• Article: ARTHRITIS & RHEUMATOLOGY. 2008;58(1):302-307

  Risks and relative risks of Wegener's granulomatosis among close relatives of patients with the disease.

  Knight A; Sandin S; Askling J
• Review: CURRENT RHEUMATOLOGY REPORTS. 2007;9(5):421-426

  Malignancy and rheumatoid arthritis.

  Askling J
• Article: ANNALS OF THE RHEUMATIC DISEASES. 2007;66(10):1339-1344

  Time-dependent increase in risk of hospitalisation with infection among Swedish RA patients treated with TNF antagonists.

  Askling J; Fored CM; Brandt L; Baecklund E; Bertilsson L; Feltelius N; Cöster L; Geborek P; Jacobsson LT; Lindblad S; Lysholm J; Rantapää-Dahlqvist S; Saxne T; van Vollenhoven RF; Klareskog L
• Article: EUROPEAN RESPIRATORY JOURNAL. 2007;30(3):414-422

  Influenza vaccination and mortality: prospective cohort study of the elderly in a large geographical area.

  Ortqvist A; Granath F; Askling J; Hedlund J
• Article: INFLAMMATORY BOWEL DISEASES. 2007;13(5):531-536

  Potential role for the common cystic fibrosis DeltaF508 mutation in Crohn's disease.

  Bresso F; Askling J; Astegiano M; Demarchi B; Sapone N; Rizzetto M; Gionchetti P; Lammers KM; de Leone A; Riegler G; Nimmo ER; Drummond H; Noble C; Torkvist L; Ekbom A; Zucchelli M; Lofberg R; Satsangi J; Pettersson S; D'Amato M
• Article: ANNALS OF THE RHEUMATIC DISEASES. 2007;66(3):414-416

  The inflammatory reflex and risk for rheumatoid arthritis: a case-control study of human vagotomy.

  Carlens C; Brandt L; Klareskog L; Lampa J; Askling J
• Article: ARTHRITIS & RHEUMATOLOGY. 2006;54(12):3774-3781

  Characteristics of diffuse large B cell lymphomas in rheumatoid arthritis.

  Baecklund E; Backlin C; Iliadou A; Granath F; Ekbom A; Amini R-M; Feltelius N; Enblad G; Sundström C; Klareskog L; Askling J; Rosenquist R
• Article: DIGESTIVE AND LIVER DISEASE. 2006;38(11):823-828

  Diagnosis underlying appendectomy and coeliac disease risk.

  Ludvigsson JF; Askling J; Ekbom A; Montgomery SM
• Review: CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION. 2006;15(11):2069-2077

  Malignant lymphomas in autoimmunity and inflammation: a review of risks, risk factors, and lymphoma characteristics.

  Smedby KE; Baecklund E; Askling J
• Article: JOURNAL OF RHEUMATOLOGY. 2006;33(10):2060-2063

  Increasing incidence of Wegener's granulomatosis in Sweden, 1975-2001.

  Knight A; Ekbom A; Brandt L; Askling J
• Article: ANNALS OF THE RHEUMATIC DISEASES. 2006;65(9):1184-1187

  Risk for malignant lymphoma in ankylosing spondylitis: a nationwide Swedish case-control study.

  Askling J; Klareskog L; Blomqvist P; Fored M; Feltelius N
• Article: CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION. 2006;15(7):1295-1300

  Incidence of non-Hodgkin's lymphoma in Sweden, Denmark, and Finland from 1960 through 2003: an epidemic that was.

  Sandin S; Hjalgrim H; Glimelius B; Rostgaard K; Pukkala E; Askling J
• Article: ANNALS OF THE RHEUMATIC DISEASES. 2006;65(6):741-745

  Impact of parental history on patients' cardiovascular mortality in rheumatoid arthritis.

  Björnådal L; Brandt L; Klareskog L; Askling J
• Review: ANNALS OF THE RHEUMATIC DISEASES. 2006;65(6):707-712

  Swedish registers to examine drug safety and clinical issues in RA.

  Askling J; Fored CM; Geborek P; Jacobsson LTH; van Vollenhoven R; Feltelius N; Lindblad S; Klareskog L
• Article: ARTHRITIS & RHEUMATOLOGY. 2006;54(3):692-701

  Association of chronic inflammation, not its treatment, with increased lymphoma risk in rheumatoid arthritis.

  Baecklund E; Iliadou A; Askling J; Ekbom A; Backlin C; Granath F; Catrina AI; Rosenquist R; Feltelius N; Sundström C; Klareskog L
• Article: INTERNATIONAL JOURNAL OF CANCER. 2006;118(2):449-452

  Personal and family history of autoimmune diabetes mellitus and susceptibility to young-adult-onset Hodgkin lymphoma.

  Landgren O; Björkholm M; Montgomery SM; Hjalgrim H; Sjöberg J; Goldin LR; Askling J
• Article: JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE. 2006;98(1):51-60

  Autoimmune and chronic inflammatory disorders and risk of non-Hodgkin lymphoma by subtype.

  Smedby KE; Hjalgrim H; Askling J; Chang ET; Gregersen H; Porwit-MacDonald A; Sundström C; Akerman M; Melbye M; Glimelius B; Adami H-O
• Article: ANNALS OF THE RHEUMATIC DISEASES. 2005;64(12):1765-1768

  Do steroids increase lymphoma risk? A case-control study of lymphoma risk in polymyalgia rheumatica/giant cell arteritis.

  Askling J; Klareskog L; Hjalgrim H; Baecklund E; Björkholm M; Ekbom A
• Article: ANNALS OF THE RHEUMATIC DISEASES. 2005;64(10):1414-1420

  Haematopoietic malignancies in rheumatoid arthritis: lymphoma risk and characteristics after exposure to tumour necrosis factor antagonists.

  Askling J; Fored CM; Baecklund E; Brandt L; Backlin C; Ekbom A; Sundström C; Bertilsson L; Cöster L; Geborek P; Jacobsson LT; Lindblad S; Lysholm J; Rantapää-Dahlqvist S; Saxne T; Klareskog L; Feltelius N
• Article: ANNALS OF THE RHEUMATIC DISEASES. 2005;64(10):1421-1426

  Risks of solid cancers in patients with rheumatoid arthritis and after treatment with tumour necrosis factor antagonists.

  Askling J; Fored CM; Brandt L; Baecklund E; Bertilsson L; Feltelius N; Cöster L; Geborek P; Jacobsson LT; Lindblad S; Lysholm J; Rantapää-Dahlqvist S; Saxne T; Klareskog L
• Article: CLINICAL AND EXPERIMENTAL RHEUMATOLOGY. 2005;23(5 Suppl 39):S195-S200

  Rheumatoid arthritis registries in Sweden.

  van Vollenhoven RF; Askling J
• Article: ARTHRITIS & RHEUMATOLOGY. 2005;52(7):1986-1992

  Risk and case characteristics of tuberculosis in rheumatoid arthritis associated with tumor necrosis factor antagonists in Sweden.

  Askling J; Fored CM; Brandt L; Baecklund E; Bertilsson L; Cöster L; Geborek P; Jacobsson LT; Lindblad S; Lysholm J; Rantapää-Dahlqvist S; Saxne T; Romanus V; Klareskog L; Feltelius N
• Article: GUT. 2005;54(5):617-622

  Risk of haematopoietic cancer in patients with inflammatory bowel disease.

  Askling J; Brandt L; Lapidus A; Karlén P; Björkholm M; Löfberg R; Ekbom A
• Article: GUT. 2005;54(1):54-59

  Malignant lymphomas in coeliac disease: evidence of increased risks for lymphoma types other than enteropathy-type T cell lymphoma.

  Smedby KE; Akerman M; Hildebrand H; Glimelius B; Ekbom A; Askling J
• Article: ANNALS OF THE RHEUMATIC DISEASES. 2004;63(10):1307-1311

  Urinary bladder cancer in Wegener's granulomatosis: risks and relation to cyclophosphamide.

  Knight A; Askling J; Granath F; Sparen P; Ekbom A
• Article: INTERNATIONAL JOURNAL OF CANCER. 2004;110(5):763-766

  Maternal breast cancer risk after the death of a child.

  Lambe M; Cerrato R; Askling J; Hsieh C-C
• Article: INTERNATIONAL JOURNAL OF CANCER. 2004;109(6):941-944

  Women smoking and testicular cancer: one epidemic causing another?

  Pettersson A; Kaijser M; Richiardi L; Askling J; Ekbom A; Akre O
• Review: CURRENT OPINION IN RHEUMATOLOGY. 2004;16(3):254-261

  Rheumatoid arthritis and malignant lymphomas.

  Baecklund E; Askling J; Rosenquist R; Ekbom A; Klareskog L
• Article: ACTA ONCOLOGICA. 2004;43(3):297-301

  Parental longevity and prognosis in elderly patients with aggressive non-Hodgkin's lymphoma.

  Osby E; Askling J; Landgren O; Dickman PW; Ekbom A; Björkholm M
• Article: GASTROENTEROLOGY. 2003;125(6):1733-1741

  Cancer risk in patients with hereditary hemochromatosis and in their first-degree relatives.

  Elmberg M; Hultcrantz R; Ekbom A; Brandt L; Olsson S; Olsson R; Lindgren S; Lööf L; Stål P; Wallerstedt S; Almer S; Sandberg-Gertzén H; Askling J
• Article: NEW ENGLAND JOURNAL OF MEDICINE. 2003;349(14):1324-1332

  Characteristics of Hodgkin's lymphoma after infectious mononucleosis.

  Hjalgrim H; Askling J; Rostgaard K; Hamilton-Dutoit S; Frisch M; Zhang J-S; Madsen M; Rosdahl N; Konradsen HB; Storm HH; Melbye M
• Article: GUT. 2003;52(10):1432-1434

  Changing pattern of paediatric inflammatory bowel disease in northern Stockholm 1990-2001.

  Hildebrand H; Finkel Y; Grahnquist L; Lindholm J; Ekbom A; Askling J
• Article: ARCHIVES OF INTERNAL MEDICINE (CHICAGO, ILL. : 1908). 2003;163(13):1566-1572

  Causes of death in patients with celiac disease in a population-based Swedish cohort.

  Peters U; Askling J; Gridley G; Ekbom A; Linet M
• Article: CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION. 2003;12(7):669-673

  Body size at birth and adulthood and the risk for germ-cell testicular cancer.

  Richiardi L; Askling J; Granath F; Akre O
• Article: PEDIATRICS. 2003;111(6 Pt 1):1343-1350

  Appendectomy during childhood and adolescence and the subsequent risk of cancer in Sweden.

  Cope JU; Askling J; Gridley G; Mohr A; Ekbom A; Nyren O; Linet MS
• Article: BMJ-BRITISH MEDICAL JOURNAL. 2003;326(7398):1068-1069

  Perinatal characteristics and risk of rheumatoid arthritis.

  Jacobsson LTH; Jacobsson ME; Askling J; Knowler WC
• Article: ARTHRITIS & RHEUMATOLOGY. 2003;48(4):963-970

  Risk of malignant lymphomas in patients with rheumatoid arthritis and in their first-degree relatives.

  Ekström K; Hjalgrim H; Brandt L; Baecklund E; Klareskog L; Ekbom A; Askling J
• Article: GASTROENTEROLOGY. 2002;123(5):1428-1435

  Cancer incidence in a population-based cohort of individuals hospitalized with celiac disease or dermatitis herpetiformis.

  Askling J; Linet M; Gridley G; Halstensen TS; Ekström K; Ekbom A
• Article: INTERNATIONAL JOURNAL OF CANCER. 2002;100(1):82-85

  Cancer incidence in a population-based cohort of patients with Wegener's granulomatosis.

  Knight A; Askling J; Ekbom A
• Article: HAEMATOLOGICA. 2002;87(6):596-601

  Parental longevity and survival in elderly patients with Hodgkin's lymphoma.

  Landgren O; Askling J; Dickman PW; Osby E; Axdorph U; Ekbom A; Björkholm M
• Article: JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE. 2002;94(9):678-681

  Hematopoietic and lymphatic cancers in relatives of patients with infectious mononucleosis.

  Hjalgrim H; Rostgaard K; Askling J; Madsen M; Storm HH; Rabkin CS; Melbye M
• Article: LANCET. 2001;358(9278):297-298

  Incidence of Hodgkin's disease in Nordic countries.

  Hjalgrim H; Askling J; Pukkala E; Hansen S; Munksgaard L; Frisch M
• Article: GASTROENTEROLOGY. 2001;120(6):1356-1362

  Family history as a risk factor for colorectal cancer in inflammatory bowel disease.

  Askling J; Dickman PW; Karlén P; Broström O; Lapidus A; Löfberg R; Ekbom A
• Article: LANCET. 2001;357(9252):262-266

  Colorectal cancer rates among first-degree relatives of patients with inflammatory bowel disease: a population-based cohort study.

  Askling J; Dickman PW; Karlén P; Broström O; Lapidus A; Löfberg R; Ekbom A
• Article: BRITISH JOURNAL OF CANCER. 2001;84(1):113-115

  Risk of non-Hodgkin's lymphoma following tuberculosis.

  Askling J; Ekbom A
• Article: JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE. 2000;92(18):1522-1528

  Risk of Hodgkin's disease and other cancers after infectious mononucleosis.

  Hjalgrim H; Askling J; Sørensen P; Madsen M; Rosdahl N; Storm HH; Hamilton-Dutoit S; Eriksen LS; Frisch M; Ekbom A; Melbye M
• Article: LANCET. 1999;354(9195):2053

  Sickness in pregnancy and sex of child.

  Askling J; Erlandsson G; Kaijser M; Akre O; Ekbom A
• Article: ANNALS OF INTERNAL MEDICINE. 1999;131(9):655-659

  Is history of squamous-cell skin cancer a marker of poor prognosis in patients with cancer?

  Askling J; Sørensen P; Ekbom A; Frisch M; Melbye M; Glimelius B; Hjalgrim H
• Article: AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE. 1999;160(5 Pt 1):1668-1672

  Increased risk for cancer following sarcoidosis.

  Askling J; Grunewald J; Eklund A; Hillerdal G; Ekbom A
• Article: LANCET. 1999;354(9185):1179

  Incidence of paediatric Crohn's disease in Stockholm, Sweden.

  Askling J; Grahnquist L; Ekbom A; Finkel Y
• Show more

Members and contact

Group leader

• 

  Johan Askling

  Professor/Senior Physician | Docent

  Telephone +46852483348

  E-mail johan.askling@ki.se

All members of the group

• 

  Peter Alping

  Postdoctoral Researcher

  Telephone +46852483226

  E-mail peter.alping@ki.se
• Luigi Annicchiarico

  Statistician

  E-mail luigi.annicchiarico@ki.se
• Pernilla Appelquist

  Administrator

  Telephone +46852483342

  E-mail pernilla.appelquist@ki.se
• 

  Elizabeth Arkema

  Principal Researcher | Docent

  E-mail elizabeth.arkema@ki.se
• 

  Johan Askling

  Professor/Senior Physician | Docent

  Telephone +46852483348

  E-mail johan.askling@ki.se
• 

  Majd Bairkdar

  Affiliated to Research

  E-mail majd.bairkdar@ki.se
• 

  Magnus Boman

  Professor

  Telephone +46852481559

  E-mail magnus.boman@ki.se
• 

  Hannah Bower

  Research Coordinator

  Telephone +46852482492

  E-mail hannah.bower@ki.se
• 

  Gustaf Bruze

  Research Coordinator

  E-mail gustaf.bruze@ki.se
• 

  Weng Che

  Affiliated to Research

  E-mail weng.che@ki.se
• 

  Marina Dehara

  Project Coordinator

  E-mail marina.dehara@ki.se
• 

  Bénédicte Delcoigne

  Statistician

  E-mail benedicte.delcoigne@ki.se
• 

  Daniela Di Giuseppe

  Statistician | Docent

  E-mail daniela.digiuseppe@ki.se
• Edit Ekström

  Project Coordinator

  Telephone +46852487499

  E-mail edit.ekstrom@ki.se
• 

  Arvid Engström

  Phd Student

  E-mail arvid.engstrom@ki.se
• 

  Thomas Frisell

  Principal Researcher | Docent

  E-mail thomas.frisell@ki.se
• 

  Karin Gunnarsson

  Phd Student

  E-mail karin.gunnarsson@ki.se
• Karin Hellgren

  Affiliated to Research

  E-mail karin.hellgren@ki.se
• 

  Marie Holmqvist

  Principal Researcher | Docent

  E-mail marie.holmqvist@ki.se
• Viking Huss

  Phd Student

  E-mail viking.huss@ki.se
• 

  Paulina Jonéus

  Postdoctoral Researcher

  E-mail paulina.joneus@ki.se
• 

  Helle Kieler

  Professor Emeritus/Emerita

  E-mail helle.kieler@ki.se
• Ingvar Krakau

  Affiliated to Research | Docent

  E-mail ingvar.krakau@ki.se
• Younes Laalou

  Phd Student

  E-mail younes.laalou@ki.se
• 

  Carl-Emil Lim

  Phd Student

  E-mail carlemil.lim@ki.se
• Lotta Ljung

  Affiliated to Research

  E-mail lotta.ljung@ki.se
• Kinda Lundström

  Phd Student

  E-mail kinda.lundstrom@ki.se
• 

  Heather Miller

  Phd Student

  E-mail heather.miller@ki.se
• 

  Viktor Molander

  Phd Student

  E-mail viktor.molander@ki.se
• 

  Martin Neovius

  Professor | Docent

  Telephone +46852482538

  E-mail martin.neovius@ki.se
• Viet Ngoc Nguyen

  Phd Student

  E-mail viet.ngoc.nguyen@ki.se
• 

  Helena Nord

  HR Administrator

  Telephone +46852483347

  E-mail helena.nord@ki.se
• Ida Palmqvist

  Project Assistant

  Telephone +46852487472

  E-mail ida.palmqvist@ki.se
• 

  Björn Pasternak

  Principal Researcher | Docent

  E-mail bjorn.pasternak@ki.se
• Karina Patasova

  Postdoctoral Researcher

  E-mail karina.patasova@ki.se
• 

  Laura Pazzagli

  Research Specialist

  E-mail laura.pazzagli@ki.se
• Gunnar Petersson

  Software Programmer

  Telephone +46852483345

  E-mail gunnar.petersson@ki.se
• 

  Maxime Raffray

  Postdoctoral Researcher

  E-mail maxime.raffray@ki.se
• Maud Rutting

  E-mail maud.rutting@ki.se
• 

  Saedis Saevarsdottir

  Researcher | Docent

  E-mail saedis.saevarsdottir@ki.se
• Elina Salonen

  Phd Student

  E-mail elina.salonen@ki.se
• 

  Julia Simard

  Affiliated to Research

  E-mail julia.simard@ki.se
• Simon Steiger

  Affiliated to Research | Statistician

  E-mail simon.steiger@ki.se
• Henrik Svanström

  Affiliated to Research

  E-mail henrik.svanstrom@ki.se
• John Svensson

  Affiliated to Research

  E-mail john.svensson@ki.se
• 

  Liselotte Tidblad

  Affiliated to Research

  E-mail liselotte.tidblad@ki.se
• 

  Peter Ueda

  Assistant Professor | Docent

  E-mail peter.ueda@ki.se
• Suvi Virtanen

  Project Coordinator | Phd Student

  Telephone +46852483217

  E-mail suvi.virtanen@ki.se
• Karin Wadström

  Postdoctoral Studies

  E-mail karin.wadstrom@ki.se
• Hjalmar Wadström

  Affiliated to Research

  E-mail hjalmar.wadstrom@ki.se
• 

  Kristin Waldenlind

  Affiliated to Research

  E-mail kristin.waldenlind@ki.se
• Sara Wedrén

  Affiliated to Research

  E-mail sara.wedren@ki.se
• 

  Helga Westerlind

  Senior Research Specialist | Docent

  Telephone +46852483354

  E-mail helga.westerlind@ki.se
• Anna-Maria Wintler

  Phd Student

  E-mail anna-maria.wintler@ki.se
• 

  Viktor Wintzell

  Coordinator

  E-mail viktor.wintzell@ki.se
• 

  Anton Öberg Sysojev

  Phd Student

  E-mail anton.oberg.sysojev@ki.se
• 

  Caroline Öfverberg Colliander

  Project Coordinator

  Telephone +46852487439

  E-mail caroline.ofverberg@ki.se